Track market-moving stories before they get noisy

A month has gone by since the last earnings report for Innovative Industrial Properties (IIPR - Free Report) . Shares have lost about 6.9% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Innovative Industrial Properties due for a breakout? Well, first let's take a quick look at its latest earnings report in order to get a better handle on the recent catalysts for Innovative Industrial Properties, Inc. before we dive into how investors and analysts have reacted as of late.

Innovative Industrial’s Q2 AFFO Beats Estimates, Revenues Miss on Tenant DefaultsInnovative Industrial reported second-quarter 2026 AFFO of $1.83 per share, up 7% year over year and beating the Zacks Consensus Estimate of $1.78 by 2.8%. Total revenues rose 0.7% to $63.31 million but missed the consensus mark of $66.47 million by 4.8%.

New leases and contractual rent escalations supported the top line, while property sales, tenant defaults and lease terminations offset much of the benefit. The operating portfolio was 95.8% leased as of June 30, 2026.

Innovative Industrial Extends Leasing Progress Across Its PortfolioRental revenues, including tenant reimbursements, were $62.89 million compared with $62.87 million a year earlier. Other revenues increased to $0.43 million from $0.03 million, leaving the overall top-line gain modest despite leasing activity.

Through June, Innovative Industrial executed five leases covering 389,000 square feet, representing 5% of total portfolio square footage.

At quarter-end, the portfolio comprised 108 properties across 19 states and 8.4 million rentable square feet. Weighted-average lease length was 11.9 years, while total invested capital stood at $2.4 billion.

Innovative Industrial Gets a Bigger Lift From IQHQInterest and other income jumped to $10.75 million from $1.57 million a year earlier. The increase primarily reflected $8.50 million of interest and dividend income from the company’s financial investments in IQHQ, along with interest on the seller-financed note tied to the Perth, NY, property sale.

Innovative Industrial fully funded its $270 million IQHQ commitment by June 30, 2026. The investment consists of a $100 million revolving credit facility carrying a 13.5% yield and $170 million of preferred equity carrying a 15% yield.

The company’s annualized base rent and income from loans and securities totaled $324.69 million at quarter-end. Cannabis represented 87.6% of the mix, life sciences 12.2% and other sources 0.2%.

Innovative Industrial Sees Mixed Expense Trends as Financing Costs RiseProperty expenses increased 4.8% year over year to $7.20 million, while general and administrative expenses declined 10.5% to $7.72 million. Interest expense climbed 87.8% to $8.35 million from $4.44 million.

On a GAAP basis, net income attributable to common stockholders rose 61.7% to $40.67 million, or $1.36 per share. Results included an $11.85 million net gain on real estate sales, which is excluded from FFO.

The quarter included a $16.70 million gain on the sale of the Perth property and a $4.90 million loss on the sale of a land parcel in San Marcos, TX. Gross proceeds from the two transactions totaled $91.77 million.

Innovative Industrial Works Through Tenant DefaultsPayments received from defaulted tenants PharmaCann and 4Front totaled $1.90 million in the second quarter, down from $3.47 million in the first quarter. PharmaCann surrendered its Ohio property in April, and the company immediately entered into a 58,000-square-foot full-building lease with Curaleaf at that location.

For 4Front, Innovative Industrial reached tentative arrangements with prospective tenants for four assets in Illinois, Washington and Massachusetts. The arrangements remain subject to contingencies, including license-transfer approvals, and are expected to become effective after receivership proceedings conclude by year-end 2026 or early 2027.

PharmaCann remained in possession of the New York and Pennsylvania properties with IIPR’s consent while working toward transfers of the existing licenses to new tenants. The company had resolved all pending litigation with PharmaCann related to its prior lease defaults.

Innovative Industrial Bolsters Liquidity and Reshapes Its Debt ProfileInnovative Industrial ended June with $204.7 million of cash and cash equivalents and total liquidity of $299.7 million. Net debt to total gross assets was 14.2%, while net debt to adjusted EBITDA stood at 1.7 times.

During the quarter, the company completed a $402.5 million offering of 6% exchangeable senior notes due 2029 and fully repaid $291 million of 5.50% unsecured notes due 2026. It also repurchased $89.0 million of common stock, while issuing common and preferred shares through its ATM programs for net proceeds of $34.8 million and $20.9 million, respectively.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.

VGM ScoresAt this time, Innovative Industrial Properties has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock was allocated a grade of B on the value side, putting it in the second quintile for value investors.

Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Interestingly, Innovative Industrial Properties has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry PlayerInnovative Industrial Properties is part of the Zacks REIT and Equity Trust - Other industry. Over the past month, Welltower (WELL - Free Report) , a stock from the same industry, has gained 3.8%. The company reported its results for the quarter ended June 2026 more than a month ago.

Welltower reported revenues of $3.54 billion in the last reported quarter, representing a year-over-year change of +39.1%. EPS of $0.61 for the same period compares with $1.28 a year ago.

For the current quarter, Welltower is expected to post earnings of $1.64 per share, indicating a change of +22.4% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.6% over the last 30 days.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Welltower. Also, the stock has a VGM Score of D.

It has been about a month since the last earnings report for Clorox (CLX - Free Report) . Shares have lost about 9.3% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Clorox due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.

Clorox Q4 Earnings & Sales Top Estimates as GOJO Supports SalesClorox delivered mixed fourth-quarter fiscal 2026 results, with the top and bottom lines surpassing the Zacks Consensus Estimate. However, sales and earnings per share declined year over year due to unfavorable comparison with ERP-related shipments in the prior-year quarter, lower volume and significant gross margin pressure from higher commodity, manufacturing and logistics costs.

CLX Q4 Key Metrics & InsightsClorox posted adjusted earnings of $1.66 per share for the fourth quarter of fiscal 2026, falling 42% year over year but beating the Zacks Consensus Estimate of $1.64 by 1.2%. Lower sales and gross margin weighed on the bottom line.

Net sales declined 2% to $1.95 billion but surpassed the consensus mark of $1.91 billion by 1.8%. The GOJO acquisition contributed about 10 percentage points to sales, while organic sales fell 13% due mainly to the ERP-related shipment comparison.

CLX Margin Contracts on Costs & Lower VolumeGross profit declined 13% to $804 million from $924 million a year ago. The gross margin declined 520 basis points (bps) year over year to 41.3%. Lower volume, GOJO inventory step-up costs, higher commodity expenses, and elevated manufacturing and logistics costs more than offset savings initiatives.
The comparison with incremental shipments ahead of the prior-year ERP transition reduced the margin by about 150 bps. The GOJO inventory step-up created another roughly 150-bps drag. The adjusted gross margin, excluding acquisition and integration costs, was 42.8%.
 

Clorox Records Higher Operating ExpensesSelling and administrative expenses increased 0.7% year over year to $298 million from $296 million in the year-ago quarter. These expenses represented 15.3% of net sales and included $21 million of GOJO integration costs.
Advertising costs rose 26.3% year over year to $216 million from $171 million, and represented 11.1% of sales. Research and development expenses were unchanged at $32 million.

CLX Posts Mixed Segment ResultsHealth and Wellness sales increased 16% year over year to $860 million. The GOJO acquisition contributed about 28 percentage points to growth. Organic sales declined 12% because of the ERP-related shipment comparison, while segment adjusted EBIT fell 15% to $206 million.

Household sales decreased 18% to $524 million, led by a 16-point volume decline and two points of unfavorable price mix. The decrease reflected the ERP comparison and shipments ahead of consumption in the fiscal third quarter. Segmental adjusted EBIT plunged 56% to $69 million amid lower sales and higher commodity costs.

Lifestyle sales declined 17% year over year to $280 million. Volume fell 14 points, while unfavorable price mix reduced growth by another three points. Segment adjusted EBIT decreased 60% to $38 million, mainly because of lower revenues.

International sales increased 4% to $281 million, primarily supported by favorable foreign exchange rates. Organic sales rose 1%. Segment adjusted EBIT advanced 17% to $27 million on higher sales and cost savings.

Clorox Issues FY27 OutlookFor fiscal 2027, CLX expects net sales growth of 13-14%, including 9.5 percentage points from GOJO. Organic sales are projected to rise 3.5-4.5%, including more than 3.5 points of benefit from lapping the ERP-related inventory drawdown.

The company expects a gross margin of 42%, as stronger-than-normal inflation and unfavorable mix are anticipated to more than offset cost savings. Selling and administrative expenses are projected at 16% of sales, while advertising spending is expected to be 10%.

Adjusted earnings are forecast between $5.70 and $6.00 per share, implying growth of 3-8% year over year. Reported earnings are expected between $5.41 and $5.71 per share, including 29 cents of GOJO transaction-related costs.

CLX Cash Flow & Balance Sheet UpdateThe fiscal 2026 operating cash flow decreased 38% year over year to $612 million due to the Glad Venture Agreement termination payment. Management expects the fiscal 2027 free cash flow to be 11-13% of net sales.

Clorox ended fiscal 2026 with $143 million in cash and cash equivalents. Long-term debt rose to $3.98 billion from $2.48 billion a year earlier, while notes and loans payable increased to $1.09 billion from $4 million following the GOJO transaction.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a downward trend in fresh estimates.

The consensus estimate has shifted -21.06% due to these changes.

VGM ScoresAt this time, Clorox has a subpar Growth Score of D, however its Momentum Score is doing a lot better with an A. However, the stock was allocated a grade of C on the value side, putting it in the middle 20% for value investors.

Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Clorox has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.

Performance of an Industry PlayerClorox belongs to the Zacks Consumer Products - Staples industry. Another stock from the same industry, Albertsons Companies, Inc. (ACI - Free Report) , has gained 3.2% over the past month. More than a month has passed since the company reported results for the quarter ended May 2026.

Albertsons Companies reported revenues of $24.94 billion in the last reported quarter, representing a year-over-year change of +0.2%. EPS of $0.42 for the same period compares with $0.55 a year ago.

Albertsons Companies is expected to post earnings of $0.33 per share for the current quarter, representing a year-over-year change of -25%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.5%.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #5 (Strong Sell) for Albertsons Companies. Also, the stock has a VGM Score of A.

A month has gone by since the last earnings report for Palantir Technologies Inc. (PLTR - Free Report) . Shares have added about 10.6% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Palantir Technologies due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important catalysts.

PLTR Beats Q2 Earnings EstimatesPalantir Technologies delivered another exceptional quarter, with second-quarter 2026 results comfortably surpassing Wall Street expectations.

Revenues reached $1.94 billion, increasing 92.8% year over year and 19% sequentially, while beating the Zacks Consensus Estimate of $1.81 billion by 7.2%.

Earnings per share came in at 41 cents, up from 16 cents a year ago, representing 156.3% year-over-year growth, while rising from the previous quarter's 34 cents (20.6% sequential growth). EPS also exceeded the consensus estimate of 35 cents by 17.1%.

Commercial Business Remains PLTR’s Primary Growth EngineCommercial revenue climbed to $945 million, increasing 109.7% year over year and accounting for nearly 49% of total quarterly revenue. Government revenue reached $990 million, rising 79% from the prior-year quarter and representing about 51% of total sales.

The company's U.S. operations remained the biggest contributor to growth. U.S. revenues totaled $1.57 billion, representing more than 81% of company-wide revenue, reflecting exceptionally strong customer demand for enterprise AI deployments.

Large contract activity remained particularly robust. During the quarter, the company closed 220 deals worth at least $1 million, reflecting increasing adoption of its Artificial Intelligence Platform across commercial enterprises and government agencies.

Margins and Cash Flow Highlight PLTR’s Operational StrengthThe company's rapid revenue expansion was accompanied by outstanding profitability. Adjusted gross margin remained exceptionally high at 86%, highlighting the scalability of Palantir's software platform. Adjusted operating margin expanded to 62%, among the highest across enterprise software companies.

Cash generation remained equally impressive. Cash from operations totaled $1.216 billion, while adjusted free cash flow reached approximately $1.22 billion during the quarter. These figures translate into an adjusted free cash flow margin of roughly 63%, illustrating Palantir's ability to convert revenue growth into substantial cash generation.

The company ended the quarter with $9.2 billion in cash, cash equivalents, and short-term U.S. Treasury securities, providing considerable financial flexibility to fund product development and future expansion initiatives.

While management acknowledged that gross margin experienced modest pressure from assuming cloud-hosting responsibilities for a government customer, executives indicated that the move should improve implementation speed and strengthen long-term customer relationships.

Bookings Show Demand Remains Exceptionally StrongBeyond reported revenue, forward-looking indicators also strengthened. Total contract value bookings reached $3.4 billion, reflecting another record quarter for customer commitments.

Net dollar retention stood at 157%, demonstrating that existing customers continue expanding their usage significantly after initial deployments.

Total remaining deal value increased to $13.1 billion, while remaining performance obligations reached $4.9 billion, providing strong visibility into future revenue growth.

These metrics suggest that Palantir's current momentum is not solely driven by recent contract wins but is increasingly supported by long-term customer expansion.

AI Platform Expands PLTR’s Competitive PositionPalantir's product strategy increasingly revolves around enabling enterprises to deploy AI models while maintaining full ownership over their data, workflows and operational knowledge.

Management emphasized that customers increasingly prioritize flexibility, allowing organizations to benchmark different AI models and replace them whenever necessary without becoming dependent on a single provider.

This positioning appears to resonate strongly with enterprises seeking greater control over rapidly evolving AI technologies. Rather than competing directly on foundation models, Palantir continues focusing on the software layer that integrates, manages and operationalizes AI across organizations.

Management also highlighted growing demand from customers that initially adopted Foundry but are now expanding toward broader AI deployments across multiple business functions.

Management Raises Guidance AgainPerhaps the most significant takeaway from the quarter was management's increased confidence in future growth. For the third quarter of 2026, Palantir expects revenues between $2.16 billion and $2.164 billion, implying another sequential increase of roughly 12% from the second quarter. Adjusted income from operations is projected between $1.292 billion and $1.296 billion.

Management also substantially increased full-year guidance. Revenues are now expected between $8.15 billion and $8.158 billion, up from the previous outlook of $7.65$7.662 billion. The midpoint of the guidance therefore increased by nearly $500 million, representing one of the company's largest upward revisions. The company also lifted its U.S. commercial revenue forecast to more than $3.424 billion compared with the earlier expectation exceeding $3.224 billion.

Adjusted operating income guidance increased to $4.889-$4.897 billion, while adjusted free cash flow guidance rose to $4.5-$4.7 billion, reinforcing management's confidence that profitability will continue improving alongside revenue growth.

How Have Estimates Been Moving Since Then?In the past month, investors have witnessed a upward trend in estimates revision.

The consensus estimate has shifted 10.74% due to these changes.

VGM ScoresCurrently, Palantir Technologies has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with an F. Following the exact same course, the stock was allocated a score of F on the value side, putting it in the fifth quintile for this investment strategy.

Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been trending upward for the stock, and the magnitude of these revisions looks promising. It comes with little surprise Palantir Technologies has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.

Performance of an Industry PlayerPalantir Technologies belongs to the Zacks Internet - Software industry. Another stock from the same industry, Automatic Data Processing (ADP - Free Report) , has gained 4.8% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.

ADP reported revenues of $5.47 billion in the last reported quarter, representing a year-over-year change of +6.8%. EPS of $2.64 for the same period compares with $2.26 a year ago.

For the current quarter, ADP is expected to post earnings of $2.78 per share, indicating a change of +11.7% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.

ADP has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of D.

Iyo Bank Ltd. bought a new position in Micron Technology, Inc. (NASDAQ:MU – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 14,298 shares of the semiconductor manufacturer’s stock, valued at approximately $16,504,000. Micron Technology accounts for about 5.0% of Iyo Bank Ltd.’s holdings, making the stock its 5th largest holding.

A number of other institutional investors have also bought and sold shares of the business. High Note Wealth LLC boosted its stake in shares of Micron Technology by 65.4% in the fourth quarter. High Note Wealth LLC now owns 86 shares of the semiconductor manufacturer’s stock worth $25,000 after acquiring an additional 34 shares during the period. Kohmann Bosshard Financial Services LLC bought a new stake in Micron Technology during the 1st quarter valued at approximately $27,000. Bayban purchased a new position in Micron Technology in the 4th quarter worth approximately $29,000. Luken Investment Analytics LLC purchased a new stake in Micron Technology during the 4th quarter valued at approximately $31,000. Finally, WealthCollab LLC grew its holdings in Micron Technology by 4,500.0% during the 2nd quarter. WealthCollab LLC now owns 276 shares of the semiconductor manufacturer’s stock valued at $34,000 after buying an additional 270 shares in the last quarter. Hedge funds and other institutional investors own 80.84% of the company’s stock.

Analyst Ratings Changes MU has been the topic of several recent analyst reports. TD Cowen reiterated a “buy” rating on shares of Micron Technology in a research report on Friday, July 10th. Citigroup cut their target price on shares of Micron Technology from $1,400.00 to $1,150.00 and set a “buy” rating for the company in a research note on Friday, August 7th. Zacks Research downgraded shares of Micron Technology from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 19th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $1,500.00 price target on shares of Micron Technology in a report on Thursday, June 25th. Finally, Wolfe Research set a $1,500.00 price target on shares of Micron Technology in a research note on Thursday, June 25th. Four investment analysts have rated the stock with a Strong Buy rating, thirty-one have issued a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Micron Technology presently has a consensus rating of “Buy” and a consensus price target of $1,295.63.

Read Our Latest Stock Analysis on MU Micron Technology Stock Down 2.6% Shares of MU opened at $933.44 on Wednesday. The stock has a market capitalization of $1.05 trillion, a price-to-earnings ratio of 21.13 and a beta of 2.22. Micron Technology, Inc. has a 1 year low of $114.25 and a 1 year high of $1,255.00. The business’s 50 day simple moving average is $944.21 and its 200-day simple moving average is $724.85. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.42 and a quick ratio of 2.98.

Micron Technology (NASDAQ:MU – Get Free Report) last posted its earnings results on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 earnings per share for the quarter, beating analysts’ consensus estimates of $21.39 by $3.72. Micron Technology had a net margin of 55.91% and a return on equity of 71.13%. The firm had revenue of $41.46 billion during the quarter, compared to analyst estimates of $35.91 billion. During the same period last year, the firm posted $1.91 earnings per share. Micron Technology’s revenue for the quarter was up 345.8% compared to the same quarter last year. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. As a group, equities analysts expect that Micron Technology, Inc. will post 72.93 earnings per share for the current fiscal year.

Micron Technology Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 21st. Shareholders of record on Monday, July 6th were paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date of this dividend was Monday, July 6th. Micron Technology’s dividend payout ratio (DPR) is presently 1.36%.

Key Headlines Impacting Micron Technology Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: Analyst earnings upgrades and optimism about Micron’s AI memory opportunity supported the bullish case. Bernstein reportedly maintained a Buy rating with a $1,300 price target, while other published targets extend as high as $2,000. Micron Technology Gains Driven by Earnings Upgrades Positive Sentiment: Micron’s latest results significantly exceeded expectations, with quarterly revenue of $41.46 billion and earnings of $25.11 per share. Revenue increased more than 345% year over year, reinforcing confidence in the current memory and AI infrastructure cycle. Positive Sentiment: Reports argue that high-bandwidth memory capacity is sold out through 2026 and supported by long-term customer agreements. This could provide unusually strong revenue visibility and help protect margins despite concerns about new competitors. Why China’s Memory Chip Breakthrough Won’t Crash the Market Positive Sentiment: Investors remain focused on the possibility that AI demand has structurally altered Micron’s historically cyclical memory business. Some commentary describes the recent pullback as an opportunity because demand for AI-related wafer capacity continues to exceed supply. Neutral Sentiment: China’s CXMT reportedly began small-batch production of HBM3E and plans LPDDR6 production, creating a longer-term competitive and geopolitical consideration. However, analysts argue that its initial output is too small to ease the global AI memory shortage in the near term. MU and SNDK Face New China Memory Challenge Neutral Sentiment: Broader semiconductor weakness, higher bond yields, oil-price volatility, and uncertainty surrounding potential tariffs have reduced investors’ willingness to pay elevated valuations for technology stocks. Negative Sentiment: Unions representing roughly two-thirds of Micron’s Taiwan workforce, or nearly 10,000 employees, threatened possible strike action unless the company increases bonuses and profit sharing. A walkout could disrupt manufacturing, raise labor costs, and delay shipments. Micron’s Taiwan Unions Threaten Strike Over Bonus Dispute Negative Sentiment: Micron’s heavy manufacturing exposure to Taiwan adds geopolitical and operational risk, while reports of widespread insider selling may reinforce investor caution after the stock’s substantial run-up. Insiders Place Their Bets In other news, EVP April S. Arnzen sold 40,000 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $1,083.94, for a total value of $43,357,600.00. Following the sale, the executive vice president directly owned 85,737 shares in the company, valued at $92,933,763.78. The trade was a 31.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Scott R. Allen sold 879 shares of the company’s stock in a transaction dated Thursday, July 23rd. The shares were sold at an average price of $1,000.00, for a total transaction of $879,000.00. Following the sale, the chief accounting officer owned 34,958 shares in the company, valued at $34,958,000. This represents a 2.45% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 177,204 shares of company stock worth $182,156,264. Insiders own 0.24% of the company’s stock.

Micron Technology Company Profile (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

Featured Articles Five stocks we like better than Micron Technology Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Fund Advisors of America Inc FL purchased a new stake in Micron Technology, Inc. (NASDAQ:MU – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,158 shares of the semiconductor manufacturer’s stock, valued at approximately $3,646,000. Micron Technology accounts for about 3.3% of Fund Advisors of America Inc FL’s holdings, making the stock its 5th biggest position.

Other hedge funds also recently made changes to their positions in the company. M.E. Allison & CO. Inc. increased its stake in Micron Technology by 0.8% in the second quarter. M.E. Allison & CO. Inc. now owns 1,324 shares of the semiconductor manufacturer’s stock valued at $1,528,000 after acquiring an additional 11 shares during the period. Cherrydale Wealth Management LLC raised its position in Micron Technology by 1.4% in the second quarter. Cherrydale Wealth Management LLC now owns 972 shares of the semiconductor manufacturer’s stock worth $1,122,000 after purchasing an additional 13 shares in the last quarter. Bellevue Asset Management LLC lifted its stake in Micron Technology by 25.5% during the second quarter. Bellevue Asset Management LLC now owns 64 shares of the semiconductor manufacturer’s stock worth $74,000 after purchasing an additional 13 shares during the period. Mowery & Schoenfeld Wealth Management LLC lifted its stake in Micron Technology by 8.8% during the second quarter. Mowery & Schoenfeld Wealth Management LLC now owns 161 shares of the semiconductor manufacturer’s stock worth $186,000 after purchasing an additional 13 shares during the period. Finally, Red Door Wealth Management LLC boosted its holdings in Micron Technology by 0.7% during the second quarter. Red Door Wealth Management LLC now owns 1,914 shares of the semiconductor manufacturer’s stock valued at $2,209,000 after purchasing an additional 14 shares in the last quarter. Institutional investors and hedge funds own 80.84% of the company’s stock.

Insider Activity at Micron Technology In other news, EVP April S. Arnzen sold 40,000 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $1,083.94, for a total value of $43,357,600.00. Following the completion of the sale, the executive vice president directly owned 85,737 shares in the company, valued at approximately $92,933,763.78. This trade represents a 31.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Lynn A. Dugle sold 1,300 shares of Micron Technology stock in a transaction dated Tuesday, June 30th. The shares were sold at an average price of $1,150.43, for a total value of $1,495,559.00. Following the completion of the transaction, the director directly owned 17,728 shares of the company’s stock, valued at $20,394,823.04. This represents a 6.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 177,204 shares of company stock valued at $182,156,264. 0.24% of the stock is currently owned by company insiders.

Micron Technology Stock Performance NASDAQ:MU opened at $933.44 on Wednesday. Micron Technology, Inc. has a 1 year low of $114.25 and a 1 year high of $1,255.00. The firm has a 50 day moving average of $944.21 and a 200-day moving average of $724.85. The company has a current ratio of 3.42, a quick ratio of 2.98 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $1.05 trillion, a P/E ratio of 21.13 and a beta of 2.22. Micron Technology (NASDAQ:MU – Get Free Report) last released its quarterly earnings results on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 EPS for the quarter, topping analysts’ consensus estimates of $21.39 by $3.72. Micron Technology had a return on equity of 71.13% and a net margin of 55.91%.The business had revenue of $41.46 billion for the quarter, compared to analyst estimates of $35.91 billion. During the same period in the prior year, the company earned $1.91 EPS. Micron Technology’s revenue for the quarter was up 345.8% on a year-over-year basis. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. As a group, sell-side analysts anticipate that Micron Technology, Inc. will post 72.93 EPS for the current fiscal year.

Micron Technology Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 21st. Stockholders of record on Monday, July 6th were issued a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.1%. The ex-dividend date was Monday, July 6th. Micron Technology’s dividend payout ratio is presently 1.36%.

Micron Technology News Roundup Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: Analyst earnings upgrades and optimism about Micron’s AI memory opportunity supported the bullish case. Bernstein reportedly maintained a Buy rating with a $1,300 price target, while other published targets extend as high as $2,000. Micron Technology Gains Driven by Earnings Upgrades Positive Sentiment: Micron’s latest results significantly exceeded expectations, with quarterly revenue of $41.46 billion and earnings of $25.11 per share. Revenue increased more than 345% year over year, reinforcing confidence in the current memory and AI infrastructure cycle. Positive Sentiment: Reports argue that high-bandwidth memory capacity is sold out through 2026 and supported by long-term customer agreements. This could provide unusually strong revenue visibility and help protect margins despite concerns about new competitors. Why China’s Memory Chip Breakthrough Won’t Crash the Market Positive Sentiment: Investors remain focused on the possibility that AI demand has structurally altered Micron’s historically cyclical memory business. Some commentary describes the recent pullback as an opportunity because demand for AI-related wafer capacity continues to exceed supply. Neutral Sentiment: China’s CXMT reportedly began small-batch production of HBM3E and plans LPDDR6 production, creating a longer-term competitive and geopolitical consideration. However, analysts argue that its initial output is too small to ease the global AI memory shortage in the near term. MU and SNDK Face New China Memory Challenge Neutral Sentiment: Broader semiconductor weakness, higher bond yields, oil-price volatility, and uncertainty surrounding potential tariffs have reduced investors’ willingness to pay elevated valuations for technology stocks. Negative Sentiment: Unions representing roughly two-thirds of Micron’s Taiwan workforce, or nearly 10,000 employees, threatened possible strike action unless the company increases bonuses and profit sharing. A walkout could disrupt manufacturing, raise labor costs, and delay shipments. Micron’s Taiwan Unions Threaten Strike Over Bonus Dispute Negative Sentiment: Micron’s heavy manufacturing exposure to Taiwan adds geopolitical and operational risk, while reports of widespread insider selling may reinforce investor caution after the stock’s substantial run-up. Analyst Ratings Changes Several equities research analysts have recently weighed in on the company. ThinkEquity reiterated a “buy” rating on shares of Micron Technology in a research note on Monday, August 3rd. Bank of America raised their target price on Micron Technology from $950.00 to $1,500.00 and gave the stock a “buy” rating in a research report on Tuesday, June 23rd. Deutsche Bank Aktiengesellschaft boosted their price target on Micron Technology from $1,500.00 to $1,550.00 and gave the company a “buy” rating in a research note on Thursday, June 25th. Mizuho dropped their price objective on Micron Technology from $1,375.00 to $1,300.00 and set an “outperform” rating for the company in a research note on Tuesday, August 25th. Finally, Morgan Stanley increased their price objective on Micron Technology from $1,050.00 to $1,200.00 and gave the stock an “overweight” rating in a research note on Thursday, June 25th. Four equities research analysts have rated the stock with a Strong Buy rating, thirty-one have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $1,295.63.

Get Our Latest Stock Report on MU

Micron Technology Company Profile (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

Featured Articles Five stocks we like better than Micron Technology Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Green Alpha Advisors LLC bought a new stake in Micron Technology, Inc. (NASDAQ:MU – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 6,644 shares of the semiconductor manufacturer’s stock, valued at approximately $7,669,000. Micron Technology makes up approximately 5.1% of Green Alpha Advisors LLC’s portfolio, making the stock its 3rd biggest holding.

Several other hedge funds have also recently added to or reduced their stakes in the company. High Note Wealth LLC lifted its position in shares of Micron Technology by 65.4% during the 4th quarter. High Note Wealth LLC now owns 86 shares of the semiconductor manufacturer’s stock worth $25,000 after purchasing an additional 34 shares during the last quarter. Kohmann Bosshard Financial Services LLC purchased a new position in Micron Technology in the first quarter valued at $27,000. Bayban purchased a new position in Micron Technology in the fourth quarter valued at $29,000. Luken Investment Analytics LLC purchased a new position in Micron Technology in the fourth quarter valued at $31,000. Finally, WealthCollab LLC raised its stake in Micron Technology by 4,500.0% in the second quarter. WealthCollab LLC now owns 276 shares of the semiconductor manufacturer’s stock valued at $34,000 after buying an additional 270 shares in the last quarter. Institutional investors and hedge funds own 80.84% of the company’s stock.

Analysts Set New Price Targets A number of analysts have issued reports on MU shares. Citigroup decreased their price target on Micron Technology from $1,400.00 to $1,150.00 and set a “buy” rating for the company in a report on Friday, August 7th. DA Davidson increased their price objective on Micron Technology from $1,500.00 to $2,000.00 and gave the company a “buy” rating in a report on Thursday, June 25th. Barclays raised their target price on Micron Technology from $1,175.00 to $2,000.00 and gave the stock an “overweight” rating in a research report on Thursday, June 25th. Royal Bank Of Canada boosted their target price on Micron Technology from $1,200.00 to $1,500.00 and gave the stock an “outperform” rating in a research note on Thursday, June 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Micron Technology from $1,500.00 to $1,550.00 and gave the company a “buy” rating in a report on Thursday, June 25th. Four investment analysts have rated the stock with a Strong Buy rating, thirty-one have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $1,295.63.

View Our Latest Report on Micron Technology Micron Technology News Roundup Here are the key news stories impacting Micron Technology this week:

Positive Sentiment: Analyst earnings upgrades and optimism about Micron’s AI memory opportunity supported the bullish case. Bernstein reportedly maintained a Buy rating with a $1,300 price target, while other published targets extend as high as $2,000. Micron Technology Gains Driven by Earnings Upgrades Positive Sentiment: Micron’s latest results significantly exceeded expectations, with quarterly revenue of $41.46 billion and earnings of $25.11 per share. Revenue increased more than 345% year over year, reinforcing confidence in the current memory and AI infrastructure cycle. Positive Sentiment: Reports argue that high-bandwidth memory capacity is sold out through 2026 and supported by long-term customer agreements. This could provide unusually strong revenue visibility and help protect margins despite concerns about new competitors. Why China’s Memory Chip Breakthrough Won’t Crash the Market Positive Sentiment: Investors remain focused on the possibility that AI demand has structurally altered Micron’s historically cyclical memory business. Some commentary describes the recent pullback as an opportunity because demand for AI-related wafer capacity continues to exceed supply. Neutral Sentiment: China’s CXMT reportedly began small-batch production of HBM3E and plans LPDDR6 production, creating a longer-term competitive and geopolitical consideration. However, analysts argue that its initial output is too small to ease the global AI memory shortage in the near term. MU and SNDK Face New China Memory Challenge Neutral Sentiment: Broader semiconductor weakness, higher bond yields, oil-price volatility, and uncertainty surrounding potential tariffs have reduced investors’ willingness to pay elevated valuations for technology stocks. Negative Sentiment: Unions representing roughly two-thirds of Micron’s Taiwan workforce, or nearly 10,000 employees, threatened possible strike action unless the company increases bonuses and profit sharing. A walkout could disrupt manufacturing, raise labor costs, and delay shipments. Micron’s Taiwan Unions Threaten Strike Over Bonus Dispute Negative Sentiment: Micron’s heavy manufacturing exposure to Taiwan adds geopolitical and operational risk, while reports of widespread insider selling may reinforce investor caution after the stock’s substantial run-up. Micron Technology Price Performance Shares of MU opened at $933.44 on Wednesday. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.42 and a quick ratio of 2.98. Micron Technology, Inc. has a 1-year low of $114.25 and a 1-year high of $1,255.00. The stock has a market cap of $1.05 trillion, a PE ratio of 21.13 and a beta of 2.22. The firm has a fifty day moving average price of $944.21 and a 200 day moving average price of $724.85.

Micron Technology (NASDAQ:MU – Get Free Report) last issued its quarterly earnings data on Wednesday, June 24th. The semiconductor manufacturer reported $25.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $21.39 by $3.72. Micron Technology had a return on equity of 71.13% and a net margin of 55.91%.The company had revenue of $41.46 billion for the quarter, compared to analyst estimates of $35.91 billion. During the same quarter last year, the company posted $1.91 earnings per share. The business’s quarterly revenue was up 345.8% compared to the same quarter last year. Micron Technology has set its Q4 2026 guidance at 30.000-32.000 EPS. As a group, sell-side analysts anticipate that Micron Technology, Inc. will post 72.93 EPS for the current year.

Micron Technology Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Tuesday, July 21st. Investors of record on Monday, July 6th were paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Monday, July 6th. Micron Technology’s dividend payout ratio (DPR) is currently 1.36%.

Insider Activity at Micron Technology In other news, Director Lynn A. Dugle sold 1,300 shares of the stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $1,150.43, for a total value of $1,495,559.00. Following the completion of the sale, the director directly owned 17,728 shares of the company’s stock, valued at approximately $20,394,823.04. This represents a 6.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP April S. Arnzen sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $1,083.94, for a total transaction of $43,357,600.00. Following the transaction, the executive vice president owned 85,737 shares in the company, valued at approximately $92,933,763.78. This trade represents a 31.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 177,204 shares of company stock valued at $182,156,264 over the last 90 days. 0.24% of the stock is owned by insiders.

Micron Technology Company Profile (Free Report)

Micron Technology, Inc is a global semiconductor company that designs and manufactures memory and storage solutions. Its product portfolio includes dynamic random-access memory (DRAM), NAND flash memory, solid-state drives (SSDs), memory modules and embedded memory solutions for a wide range of computing and electronic devices. Micron supplies components used in data centers, enterprise and cloud infrastructure, client computing, mobile devices, automotive systems and industrial applications, and also markets consumer-facing products under the Crucial brand.

Founded in 1978 and headquartered in Boise, Idaho, Micron has grown into an international manufacturer with research, development and production facilities across multiple regions.

Further Reading Five stocks we like better than Micron Technology Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery Want to see what other hedge funds are holding MU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Micron Technology, Inc. (NASDAQ:MU – Free Report).

Receive News & Ratings for Micron Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Micron Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways Teladoc Health is expanding through chronic care, international growth and its upcoming Teladoc One platform.BetterHelp revenues fell 11.6%, while its adjusted EBITDA margin dropped to 0.2% in Q2 2026.TDOC remains unprofitable and faces intense virtual-care competition that could pressure growth and pricing. Teladoc Health, Inc. (TDOC - Free Report) is well-positioned for growth, supported by broad clinical capabilities, connected-care innovation, strategic acquisitions and an expanding international presence. Over the past six months, TDOC stock has gained 22.7% compared with the industry’s 5.9% growth.

With a market capitalization of approximately $1.1 billion, TDOC operates through two main segments — Integrated Care and BetterHelp. From a valuation standpoint, the stock appears to be trading at a discount. The company has a forward Price-to-Sales ratio of 0.47X, which is below the industry average of 0.53X.

Courtesy of solid prospects, TDOC currently carries a Zacks Rank #3 (Hold) and a Value Score of B.

Where Do Estimates for TDOC Stand?The Zacks Consensus Estimate for Teladoc Health’s 2026 loss is pegged at 89 cents per share, suggesting a 21.9% year-over-year increase. In the past 30 days, it has witnessed three upward estimate revisions against one in the opposite direction. The consensus estimate for revenues is pegged at $2.4 billion for 2026.

TDOC beat earnings estimates in three of the past four quarters and missed once, with an average surprise of 11.4%.

TDOC’s Growth DriversTeladoc Health’s growth prospects are increasingly tied to deeper penetration of its Integrated Care platform, particularly chronic care. Chronic Care Program enrollment reached 1.27 million at the end of June 2026, up 14% year over year, helped by greater adoption of multi-condition bundles. In the second quarter of 2026, Integrated Care revenues increased 0.7% year over year to $394.3 million, with hybrid care revenues rising 30%.

International expansion and broader distribution channels provide another avenue for growth. International revenues increased 7% year over year to $119.6 million in the second quarter of 2026. The company expects international revenues to grow in the high-single digit on an organic constant-currency basis in 2026. The Telecare acquisition also contributed to Integrated Care’s revenue growth in the second quarter, supporting Teladoc Health’s international expansion strategy. Additionally, partnerships with platforms such as Walmart are extending Teladoc Health’s reach beyond traditional employer and health-plan channels, giving consumers easier access to virtual urgent care, dermatology and nutrition services.

A major part of Teladoc Health’s next phase is Teladoc One, a more unified care model that combines multidisciplinary care teams, connected health data and always-on AI support. The platform is designed to coordinate care across chronic conditions, mental health, primary care and other needs rather than treating each condition separately. Programs are scheduled to begin with select clients in September 2026, followed by broader availability in January 2027.

Meanwhile, BetterHelp is undergoing a strategic shift toward insurance-based, in-network services, which could create a more durable growth model over time. The company has contracted for more than 150 million in-network lives and credentialed more than 8,000 mental-health professionals. TDOC is also investing in provider recruitment, network capacity, platform efficiency and targeted marketing to support further growth in its insurance-based business.

Risks for TDOC StockThere are some factors, however, that investors should keep a careful eye on.

BetterHelp remains a key concern for Teladoc Health as weakness in the cash-pay mental health business continues to weigh on results. BetterHelp revenues declined 11.6% year over year to $212.6 million in the second quarter of 2026, while its adjusted EBITDA margin fell to just 0.2%.

Teladoc Health faces intense competition in the virtual care market, which could pressure pricing and growth. The company also remains unprofitable, reporting an accumulated deficit of $16.5 billion as of June 30, 2026, largely due to substantial investments in growth initiatives and technology.

Stocks to ConsiderSome better-ranked stocks in the Medical space are BrightSpring Health Services, Inc. (BTSG - Free Report) , Globus Medical, Inc. (GMED - Free Report) and Centene Corporation (CNC - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for BrightSpring Health Services’ current-year earnings of $1.82 per share has witnessed two upward revisions in the past 30 days against no movement in the opposite direction. BTSG beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 16.1%. The consensus estimate for current-year revenues is pegged at $15.3 billion, suggesting 18.2% year-over-year growth.

The Zacks Consensus Estimate for Globus Medical’s current-year earnings of $4.99 per share has witnessed one upward revision in the past seven days, against no movement in the opposite direction. GMED beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.9%. The consensus estimate for current-year revenues is pegged at $3.2 billion, suggesting 8.8% year-over-year growth.

The Zacks Consensus Estimate for Centene’s current-year earnings of $4.89 per share has witnessed two upward revisions in the past 30 days, against no movement in the opposite direction. CNC beat earnings estimates in each of the trailing four quarters, with an average surprise of 151.3%. The consensus estimate for current-year revenues is pegged at $196.3 billion, suggesting 0.8% year-over-year growth.

Key Takeaways TSMC is adding $100B in Arizona, bringing its total state investment to $265B.TSMC's overseas fab ramps could dilute gross margins 2%-4%, while N2 may cut margins 3-4 points.TSMC raised 2026 revenue growth guidance to slightly above 40% on strong AI-driven demand. Taiwan Semiconductor Manufacturing Company (TSM - Free Report) , or TSMC, is stepping up its capital expenditures to increase its production capacity and support the future growth of its customers. The company has announced an additional $100 billion investment in Arizona, taking its total investment in the state to $265 billion. The new spending will support the construction of several more semiconductor logical wafer fabs for 2-nanometer (N2) and below technologies, as well as advanced packaging fabs to address the strong multiyear demand from its leading U.S. customers.

The capacity expansion also spans markets outside the United States. TSMC is building 13 leading-edge and advanced packaging fabs in Taiwan over the next several years while also increasing its mature node capacity through JASM Fab 1 in Japan for complementary metal oxide semiconductor image sensor applications and European Semiconductor Manufacturing Company in Germany for automotive and industrial applications.

However, TSMC’s global expansion could weigh on profitability in the near term. Management projects gross margin dilution from overseas fab ramp-up to range from 2% to 3% initially, rising to 3%-4% at later stages. The steep ramp-up of N2 technology is expected to dilute gross margins by 3 to 4 percentage points in the second half of 2026.

Meanwhile, the AI megatrend continues to fuel strong demand for TSMC’s leading-edge technologies as computing needs rise. The company is using its manufacturing capabilities to generate more wafer output and drive greater capacity optimization across nodes in its fab operations to support profitability. With its technology differentiation and broad customer base, TSMC expects full-year 2026 revenue growth to be slightly above 40% year over year in U.S. dollar terms, up from the previous guidance of above 30%.

TSM’s Peer UpdatesBroadcom (AVGO - Free Report) recently introduced VMware Private AI Cloud, a more secure, scalable, and flexible approach to AI that brings the model to the data rather than moving data to the model.Built on Broadcom's advanced software capabilities, VMware Private AI Cloud provides organizations with a production-ready path to securely building, running and governing inference workloads, agentic applications, and traditional enterprise workloads in a single private cloud platform. The company also unveiled VMware AI Factory, the software-defined foundation of VMware Private AI Cloud.

Qualcomm Technologies, Inc. (QCOM - Free Report) announced the Qualcomm Dragonwing Q-2390 and IQ-2390 processors, expanding its Dragonwing portfolio with highly integrated platforms designed to make intelligent edge computing more accessible to consumer, commercial and industrial segments. The processors will help bring AI, vision, connectivity and security to a broader range of connected devices, to power the next wave of intelligence across homes, businesses, cities and factories. 

The Zacks Rundown for TSM Stock

Year to date, TSMC shares have rallied 36.3%, slightly below the industry’s 36.7% growth.

Image Source: Zacks Investment Research

TSM currently trades at a forward sales multiple of 10.76 over the past 12 months compared with the industry average of 10.80.

Image Source: Zacks Investment Research

TSMC’s earnings estimates have been consistently revised upward over the past three months, as shown below. 

Image Source: Zacks Investment Research

TSMC sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

Aberdeen Wealth Management LLC acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 9,291 shares of the healthcare product maker’s stock, valued at approximately $843,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Visionary Wealth Advisors purchased a new position in shares of Abbott Laboratories during the 2nd quarter worth $348,000. Ames National Corp purchased a new stake in Abbott Laboratories in the 2nd quarter valued at about $211,000. Asset One Wealth Management LLC purchased a new stake in Abbott Laboratories in the 2nd quarter valued at about $328,000. Safeguard Investment Advisory Group LLC acquired a new position in Abbott Laboratories in the second quarter valued at about $273,000. Finally, Ally Financial Inc. purchased a new position in Abbott Laboratories during the second quarter worth about $7,350,000. Hedge funds and other institutional investors own 75.18% of the company’s stock.

Wall Street Analysts Forecast Growth ABT has been the subject of several research reports. BTIG Research lifted their target price on shares of Abbott Laboratories from $131.00 to $134.00 and gave the company a “buy” rating in a report on Friday, July 17th. Piper Sandler restated an “overweight” rating and set a $118.00 price target (up from $115.00) on shares of Abbott Laboratories in a research report on Friday, July 17th. Wells Fargo & Company lifted their price objective on Abbott Laboratories from $109.00 to $112.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Wolfe Research upgraded Abbott Laboratories from a “peer perform” rating to an “outperform” rating and set a $130.00 price objective on the stock in a report on Thursday, August 13th. Finally, JPMorgan Chase & Co. raised their target price on Abbott Laboratories from $110.00 to $120.00 and gave the company an “overweight” rating in a report on Friday, July 17th. Three analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $119.50.

Check Out Our Latest Report on ABT Abbott Laboratories News Summary Here are the key news stories impacting Abbott Laboratories this week:

Positive Sentiment: New infant formula expands Abbott’s nutrition portfolio. Abbott launched Similac 360 Total Care Made With Whole Milk, described as the first commercially sterile, ready-to-feed liquid whole-milk infant formula available in the U.S. The product targets growing parental interest in whole-milk formulas while offering convenience at a price similar to Similac’s powdered formula. Wider distribution and consumer adoption could provide incremental growth for Abbott’s Nutrition segment. Abbott launches whole-milk liquid infant formula Positive Sentiment: Analysts remain optimistic despite relative underperformance. Coverage notes that ABT has lagged the broader healthcare sector over the past year, but Wall Street analysts continue to express confidence in the company’s outlook. Recent earnings also showed revenue growth, an earnings-per-share beat and reaffirmed 2026 guidance, supporting the bullish view. Abbott stock and healthcare-sector performance Neutral Sentiment: Abbott is positioning the launch around changing consumer and policy preferences. The whole-milk formula introduction aligns with interest in “Make America Healthy Again” themes, but the financial impact will depend on demand, pricing and market share gains. Abbott and the Make America Healthy Again movement Negative Sentiment: Formula-related advertising scrutiny remains a risk. In a challenge brought by Abbott, the National Advertising Division supported certain Kendamil whole-milk claims but recommended that other nutritional, ingredient and heritage claims be modified or discontinued. The decision is not a direct finding against Abbott, but it highlights competitive scrutiny in the infant-formula market. NAD decision on Kendamil infant formula claims Abbott Laboratories Stock Performance Shares of Abbott Laboratories stock opened at $108.86 on Wednesday. Abbott Laboratories has a one year low of $81.97 and a one year high of $137.49. The company has a market cap of $188.37 billion, a PE ratio of 35.23, a P/E/G ratio of 2.05 and a beta of 0.59. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.97 and a current ratio of 1.38. The business has a 50-day simple moving average of $103.43 and a 200-day simple moving average of $100.09.

Abbott Laboratories (NYSE:ABT – Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare product maker reported $1.31 EPS for the quarter, topping the consensus estimate of $1.28 by $0.03. Abbott Laboratories had a net margin of 11.65% and a return on equity of 17.69%. The company had revenue of $12.59 billion during the quarter, compared to analysts’ expectations of $12.52 billion. During the same quarter in the previous year, the business posted $1.26 EPS. The firm’s revenue was up 13.0% on a year-over-year basis. Abbott Laboratories has set its Q3 2026 guidance at 1.380-1.46 EPS and its FY 2026 guidance at 5.450-5.60 EPS. On average, equities research analysts forecast that Abbott Laboratories will post 5.52 EPS for the current fiscal year.

Abbott Laboratories Dividend Announcement The business also recently disclosed a quarterly dividend, which was paid on Monday, August 17th. Shareholders of record on Wednesday, July 15th were issued a dividend of $0.63 per share. The ex-dividend date of this dividend was Wednesday, July 15th. This represents a $2.52 dividend on an annualized basis and a yield of 2.3%. Abbott Laboratories’s dividend payout ratio (DPR) is presently 81.55%.

Abbott Laboratories Profile (Free Report)

Abbott Laboratories is a global healthcare company headquartered in Abbott Park, Illinois, that develops, manufactures and markets a broad portfolio of medical products and services. Founded in 1888, Abbott operates through multiple business areas that focus on diagnostics, medical devices, nutritionals and established pharmaceuticals. The company supplies hospitals, clinics, laboratories, retailers and direct-to-consumer channels with products intended to diagnose, treat and manage a wide range of health conditions.

In diagnostics, Abbott provides laboratory and point-of-care testing platforms and assays used to detect infectious diseases, chronic conditions and biomarkers; its Alinity family of instruments and rapid-test solutions are examples of this capability.

See Also Five stocks we like better than Abbott Laboratories Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery

Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Key Takeaways RTX outperformed its industry over six months despite a 0.7% share-price decline.Defense demand, capacity expansion and major contracts support RTX's long-term growth prospects.RTX's rising earnings estimates and solid liquidity are offset by a premium industry valuation. RTX Corporation (RTX - Free Report) stock has lost 0.7% in the past six months, outperforming the Zacks Aerospace-Defense industry’s decline of 15.8%. It also outperformed the broader Zacks Aerospace sector’s decline of 15.9%. However, it underperformed the S&P 500’s return of 11.6% in the same time frame.

Image Source: Zacks Investment Research

Other industry players, such as General Dynamics (GD - Free Report) and Embraer (EMBJ - Free Report) , have delivered a similar performance in the past six months. Shares of GD and EMBJ have gained 1.3% and 3.8%, respectively, in the said period.

RTX’s stronger performance than the broader aerospace and defense industry, along with gains by key peers, may make the stock attractive to investors. However, it is important to assess whether RTX’s strong fundamentals and growth prospects can support sustainable long-term gains. Evaluating the company’s growth drivers, earnings outlook and key risks will be important for determining whether the stock has further upside.

Tailwinds for RTXRTX continues to strengthen its aerospace and defense business through higher production capacity, major contract wins and advances in defense technology. In August 2026, RTX completed a 17,000-square-foot expansion of its Forest, MS, manufacturing facility, backed by a $50 million investment. The expansion will increase production capacity for electronic warfare and radar systems and is expected to create 100 high-skilled jobs by 2028.

RTX is also increasing production of Tomahawk cruise missiles following a $22.9 billion multi-year contract from the U.S. Navy. The contract supports plans to increase annual production to more than 1,000 Tomahawk missiles and related support. RTX is investing in its workforce, technology, supply chain and facilities to meet rising demand from the U.S. Navy and its allies.

In addition, RTX continues to develop new technologies for the F-35 program. In August 2026, RTX completed altitude testing of its next-generation Enhanced Power and Cooling System (EPACS). The system is designed to provide greater cooling capacity and support future upgrades, helping maintain the F-35’s performance throughout its service life.

These developments highlight RTX’s focus on expanding production, supporting major defense programs and developing advanced technologies. Strong demand for missile systems, radar, electronic warfare and F-35 technologies could support RTX’s long-term defense growth and strengthen its position in the global aerospace and defense market.

Estimates for RTX’s 2026 Sales and EarningsThe Zacks Consensus Estimate for RTX’s 2026 sales implies year-over-year growth of 8.4%. The consensus estimate for its 2026 earnings indicates a year-over-year increase of 14.8%.

Image Source: Zacks Investment Research

The stock’s annual bottom-line estimates have moved north over the past 60 days.

Image Source: Zacks Investment Research

RTX’s ValuationIn terms of valuation, RTX’s forward 12-month price-to-sales (P/S) is 2.76X, a premium to the industry average of 2.38X. This suggests that investors will be paying a higher price than the company's expected sales growth compared with its industry average.

Image Source: Zacks Investment Research

General Dynamics and Embraer are trading at a discount in comparison with RTX. GD’s forward 12-month price-to-sales is 1.74X, while EMBJ’s forward 12-month price-to-sales is 1.42X.

Liquidity Position of RTXRTX has a current ratio of 1.01. The ratio, being more than one, indicates that RTX possesses sufficient capital to pay off its short-term debt obligations.

Its industry peers, General Dynamics and Embraer, also maintain current ratios above one. GD has a current ratio of 1.44, while EMBJ also holds 1.44.

What Should an Investor do Now?RTX’s strong defense demand, rising earnings estimates and solid liquidity position support its long-term growth prospects. However, the stock trades at a premium valuation compared with the industry and key peers, which could limit near-term upside.

Given this balance of strengths and valuation concerns, existing shareholders may consider holding the stock, while new investors may prefer to wait for a better entry point. Monitoring RTX’s earnings growth, valuation and execution will be important before taking a fresh position.

RTX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Gambit Capital Management LLC acquired a new stake in Broadcom Inc. (NASDAQ:AVGO – Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,645 shares of the semiconductor manufacturer’s stock, valued at approximately $621,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. ROSS JOHNSON & Associates LLC lifted its holdings in shares of Broadcom by 1,320.0% in the 4th quarter. ROSS JOHNSON & Associates LLC now owns 71 shares of the semiconductor manufacturer’s stock valued at $25,000 after buying an additional 66 shares during the period. Networth Advisors LLC grew its holdings in Broadcom by 546.2% during the first quarter. Networth Advisors LLC now owns 84 shares of the semiconductor manufacturer’s stock worth $26,000 after acquiring an additional 71 shares during the period. SWAN Capital LLC grew its holdings in Broadcom by 261.9% during the fourth quarter. SWAN Capital LLC now owns 76 shares of the semiconductor manufacturer’s stock worth $26,000 after acquiring an additional 55 shares during the period. Harborfront Financial Group LLC purchased a new position in Broadcom in the second quarter worth $38,000. Finally, Camelot Portfolios LLC purchased a new position in Broadcom in the fourth quarter worth $45,000. Hedge funds and other institutional investors own 76.43% of the company’s stock.

Broadcom Trading Down 0.2% NASDAQ:AVGO opened at $369.68 on Wednesday. Broadcom Inc. has a 52-week low of $287.17 and a 52-week high of $495.00. The company has a quick ratio of 2.01, a current ratio of 2.24 and a debt-to-equity ratio of 0.71. The stock has a fifty day simple moving average of $384.43 and a 200-day simple moving average of $376.88. The company has a market capitalization of $1.76 trillion, a PE ratio of 61.61, a price-to-earnings-growth ratio of 0.71 and a beta of 1.44.

Broadcom (NASDAQ:AVGO – Get Free Report) last issued its quarterly earnings data on Wednesday, June 3rd. The semiconductor manufacturer reported $2.44 EPS for the quarter, beating analysts’ consensus estimates of $2.40 by $0.04. Broadcom had a net margin of 38.85% and a return on equity of 41.61%. The firm had revenue of $22.19 billion for the quarter, compared to analysts’ expectations of $22.13 billion. During the same period in the prior year, the company earned $1.58 EPS. The firm’s revenue was up 47.9% on a year-over-year basis. On average, equities research analysts expect that Broadcom Inc. will post 10.24 earnings per share for the current fiscal year. Insider Buying and Selling at Broadcom In other news, Director Gayla J. Delly sold 1,890 shares of the firm’s stock in a transaction that occurred on Wednesday, July 8th. The shares were sold at an average price of $385.38, for a total transaction of $728,368.20. Following the completion of the transaction, the director directly owned 31,326 shares of the company’s stock, valued at $12,072,413.88. This trade represents a 5.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Mark David Brazeal sold 25,000 shares of Broadcom stock in a transaction that occurred on Friday, July 10th. The stock was sold at an average price of $401.33, for a total value of $10,033,250.00. Following the transaction, the insider owned 194,989 shares of the company’s stock, valued at $78,254,935.37. This represents a 11.36% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 61,644 shares of company stock worth $24,016,214 over the last ninety days. 1.90% of the stock is currently owned by company insiders.

Key Broadcom News Here are the key news stories impacting Broadcom this week:

Positive Sentiment: Broadcom unveiled VMware Private AI Cloud, including VMware AI Factory, AI-ready data foundations and support for more than 150 commercial and open-source models. The platform is designed to reduce AI infrastructure deployment from weeks to hours, improve GPU utilization and give enterprises greater control over AI costs. Broadcom launches private AI cloud tools Positive Sentiment: New VMware capabilities—AgentMinder, vDefend and Avi Load Balancer—target security, identity, governance and observability for autonomous AI agents. The launches could strengthen Broadcom’s position in enterprise hybrid-cloud and private-AI deployments while creating additional infrastructure-software opportunities. Broadcom agentic AI security announcement Positive Sentiment: Broadcom also launched TrueSource, a commercially supported portfolio of verified open-source software covering Spring, Java, Python, Node.js, PostgreSQL, MySQL and other data engines. The offering may expand recurring software revenue and address growing enterprise demand for secure software supply chains. Broadcom TrueSource announcement Neutral Sentiment: Analysts expect another sharp increase in quarterly results, with consensus estimates cited near $29.4 billion in revenue and $3.24 in EPS. Investors will focus on AI-chip demand, hyperscaler custom-ASIC growth, VMware execution, margins and forward guidance when AVGO reports after the market closes on September 2. Broadcom Q3 earnings preview Neutral Sentiment: Optimistic coverage points to a median analyst price target of $525 and potential upside from backlog strength, while technical commentary identifies the current area as important support. However, the stock’s reaction may depend more on results and guidance than on existing bullish targets. Broadcom Wall Street outlook Negative Sentiment: Semiconductor shares broadly weakened as a global bond selloff pushed long-term yields higher, pressuring high-multiple technology stocks. Broadcom also faces elevated expectations, a valuation near 62 times earnings, margin concerns and competitive pressure from Nvidia, Nutanix and Microsoft. Reported insider activity is heavily weighted toward sales, adding another cautionary signal. Semiconductor stocks and rising yields Wall Street Analyst Weigh In Several brokerages have commented on AVGO. Wells Fargo & Company restated an “overweight” rating and set a $545.00 target price (up from $430.00) on shares of Broadcom in a research report on Thursday, May 14th. Truist Financial increased their price target on shares of Broadcom from $545.00 to $550.00 and gave the company a “buy” rating in a report on Thursday, June 4th. Mizuho raised their price objective on shares of Broadcom from $480.00 to $530.00 and gave the company an “outperform” rating in a research note on Thursday, June 4th. Bank of America boosted their price objective on shares of Broadcom from $450.00 to $530.00 and gave the stock a “buy” rating in a report on Thursday, June 4th. Finally, Rosenblatt Securities restated a “buy” rating and set a $500.00 target price on shares of Broadcom in a research report on Thursday, June 4th. Twenty-nine investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $491.97.

Get Our Latest Research Report on AVGO

About Broadcom (Free Report)

Broadcom Inc (NASDAQ: AVGO) is a global technology company that designs, develops and supplies semiconductor and infrastructure software solutions for a broad range of markets. The company’s semiconductor business provides components and systems for wired and wireless communications, enterprise and cloud storage, networking and broadband access, serving original equipment manufacturers, cloud service providers, telecommunications carriers and industrial customers worldwide. Broadcom is headquartered in Irvine, California, and operates globally with research, development and sales organizations across North America, Europe and Asia.

On the semiconductor side, Broadcom’s portfolio includes system-on-chip (SoC) and application-specific integrated circuit (ASIC) solutions, radio-frequency and connectivity components, Ethernet switching and PHY devices, storage adapters and controllers, optical transceivers and other networking silicon.

Featured Articles Five stocks we like better than Broadcom Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery

Receive News & Ratings for Broadcom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Broadcom and related companies with MarketBeat.com's FREE daily email newsletter.

It has been about a month since the last earnings report for Tyson Foods (TSN - Free Report) . Shares have lost about 6.3% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Tyson due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.

Tyson Foods Q3 Earnings & Revenues Miss Estimates, Volumes Fall Y/YTyson Foods reported solid third-quarter fiscal 2026 results, with the top line remaining relatively flat compared with the prior year and the bottom line increasing year over year. However, both revenues and earnings miss the Zacks Consensus Estimate.

Tyson Foods posted adjusted earnings of 99 cents per share, which miss the Zacks Consensus Estimate of $1.03. The bottom line increased 9% from 91 cents in the year-ago quarter.

Total sales of $13,868 million were in line with the prior year quarter’s $13,884 million. Excluding a $98 million legal contingency accrual recorded as a reduction to sales in the current-year quarter, sales increased 0.6%. The top line missed the Zacks Consensus Estimate of $14,139 million. Average price changes had a 3.4% positive impact on the top line, while total volumes dipped 2.8% year over year.

The gross profit in the quarter was $921 million, down from $1,141 million reported in the year-ago period.

Adjusted operating income rose 8.3% year over year to $547 million. The adjusted operating margin expanded 30 basis points to 3.9%.

Decoding TSN’s Segmental DetailsBeef: Sales in the segment decreased to $5,391 million from $5,603 million reported in the year-ago quarter. Volumes fell 15.9% and the average price jumped 12.1% in the segment.

Pork: Sales in the segment increased to $1,580 million from $1,506 million reported in the year-ago quarter. Volumes grew 5.2% and the average price decreased 0.3%.

Chicken: Sales in the segment improved to $4,255 million from $4,220 million reported in the year-ago quarter. Volumes grew 1% and the average price was up 2.2%.

Prepared Foods: Sales in the segment came in at $2,557 million, up from $2,515 million reported in the year-ago quarter. Volumes grew 0.1% and the average price rose 1.6%.

International: Sales in the segment were $601 million compared with $557 million reported in the year-ago quarter. Volumes fell 3.5%, whereas the average sales price increased 11.4%.

Tyson Foods’ Other Financial UpdatesThe company exited the quarter with cash and cash equivalents of $740 million, long-term debt of $6,579 million and total shareholders’ equity (including non-controlling interests) of $18,185 million.

For the first nine months of fiscal 2026, cash provided by operating activities totaled $1,469 million, while capital expenditures were $556 million. For fiscal 2026, Tyson Foods expects capital expenditures in the range of $700 million to $900 million, primarily indicating investments in profit improvement, as well as maintenance and repair projects. The company expects free cash flow of $1.3 billion to $1.7 billion for fiscal 2026.

What to Expect From TSN in FY26?For fiscal 2026, the United States Department of Agriculture (“USDA”) anticipates domestic protein production (beef, pork, chicken and turkey) to rise around 1% compared with the level of fiscal 2025.

For the Beef segment, the USDA projects domestic protein production to dip nearly 3% year over year. The company expects an adjusted operating loss of $500-$650 million in fiscal 2026, compared with its earlier guidance of a $350-$500 million loss.

For Pork, the USDA projects domestic production to rise nearly 2%. The company expects adjusted operating income of $250-$300 million.

For Chicken, the USDA anticipates domestic production to grow about 3% year over year. The company still expects adjusted operating income of $1.9-$2.05 billion.

For Prepared Foods, management projects adjusted operating income of $1.3-$1.35 billion for fiscal 2026, compared with its previous forecast of $1.25-$1.35 billion.

For International, management projects adjusted operating income of $150-$200 million for fiscal 2026.

The company’s total revenue growth is anticipated in the range of 2.5-3.5% in fiscal 2026 compared with the fiscal 2025 level. Adjusted operating income is envisioned in the $2.1-$2.3 billion band, compared with its earlier guidance of $2.2-$2.4 billion.

How Have Estimates Been Moving Since Then?It turns out, estimates review flatlined during the past month.

The consensus estimate has shifted -7.6% due to these changes.

VGM ScoresCurrently, Tyson has a average Growth Score of C, however its Momentum Score is doing a lot better with an A. Following the exact same course, the stock has a grade of A on the value side, putting it in the top quintile for this investment strategy.

Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.

Outlook Tyson has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.

Performance of an Industry PlayerTyson is part of the Zacks Food - Meat Products industry. Over the past month, Pilgrim's Pride (PPC - Free Report) , a stock from the same industry, has gained 15.3%. The company reported its results for the quarter ended June 2026 more than a month ago.

Pilgrim's Pride reported revenues of $4.63 billion in the last reported quarter, representing a year-over-year change of -2.8%. EPS of $0.64 for the same period compares with $1.70 a year ago.

For the current quarter, Pilgrim's Pride is expected to post earnings of $0.75 per share, indicating a change of -50.7% from the year-ago quarter. The Zacks Consensus Estimate has changed -17.6% over the last 30 days.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #5 (Strong Sell) for Pilgrim's Pride. Also, the stock has a VGM Score of B.

It has been about a month since the last earnings report for Alexandria Real Estate Equities (ARE - Free Report) . Shares have added about 5.7% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Alexandria Real Estate Equities due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.

Alexandria's Q2 FFO Beats Estimates on Leasing Momentum, Rental Rates ImproveAlexandria reported second-quarter 2026 FFO, as adjusted, per share of $1.73, beating the Zacks Consensus Estimate of $1.65 by 4.9%. FFO declined 25.8% from $2.33 in the year-ago quarter.

Revenues fell 13% year over year to $662.8 million but surpassed the consensus estimate of $649 million by 2.1%. The results benefited from leasing volume exceeding 1 million rentable square feet, strong tenant collections and continued development deliveries.

Alexandria's Leasing Volume Accelerates in Q2Alexandria executed leases covering approximately 1 million RSF, up 60% from 647,356 square feet in the preceding quarter. The total also exceeded the second-quarter 2025 through first-quarter 2026 quarterly average of 952,365 RSF by roughly 87,000 RSF.

Lease renewals and re-leasing accounted for 640,998 square feet. Leasing of previously vacant space totaled 329,148 square feet, while development and redevelopment leasing contributed 68,771 square feet. Existing tenants generated 68% of the reported quarter's leasing activity.

Alexandria's Rental Rates Show ImprovementRental rates on lease renewals and re-leasing of space declined 0.7% during the second quarter, marking a sharp improvement from the 15% decrease recorded in the first quarter of 2026. On a cash basis, rental rates fell 4.3% compared with a 15.8% decline in the prior quarter.

The tenant base continued to support cash-flow visibility. Investment-grade or publicly traded large-cap tenants generated 57% of annual rental revenues. Moreover, 97% of leases contained annual rent escalations, while the weighted-average remaining lease term stood at 7.7 years.

Alexandria's Occupancy Remains Under PressureOccupancy of operating properties was 86.9% as of June 30, 2026, down from 87.7% at the end of March 2026. The decline reflected previously disclosed lease expirations and the reclassification of space at 3000 Minuteman Road from redevelopment to operating.

Executed leases covering 1.4 million RSF have not yet commenced. Including this space, occupancy would have been 90.9%. These leases are expected to generate approximately $69 million in annual rental revenues, with a weighted-average future occupancy date of November 2026.

Alexandria's Same-Property NOI DeclinesSame-property NOI decreased 10.6% year over year, while same-property NOI on a cash basis declined 8.6%. The drop was due to lower occupancy, primarily reflecting previously disclosed lease expirations with expected downtime.

The company’s operating margin was 69%, while the adjusted EBITDA margin came in at 67%. Interest expense increased 16.4% year over year to $64.3 million, reflecting the impact of debt issued at higher rates and the repayment or repurchase of lower-cost borrowings.

Alexandria Advances Its Development PipelineDuring the second quarter, Alexandria placed into service a 426,927-RSF development project occupied by Bristol Myers Squibb in San Diego. The property generated incremental annual NOI of $57 million.

The company expects projects scheduled for delivery in the second half of 2026 to contribute approximately $42 million in incremental annual NOI.

Alexandria Maintains Strong LiquidityAlexandria ended the second quarter with $3.60 billion of liquidity and a weighted-average remaining debt term of 9.7 years. Only 6% of total debt matures through 2028. Net debt and preferred stock to adjusted EBITDA was 7.0X, while fixed-charge coverage was 3.3X on a quarter-annualized basis.

The company is targeting a fourth-quarter 2026 annualized leverage ratio of 5.6 to 6.2. Alexandria expects dispositions, partial-interest sales and other capital sources to help improve leverage during the second half of 2026.

Alexandria Narrows Its 2026 FFO OutlookAlexandria narrowed its 2026 adjusted FFO guidance to $6.35-$6.45 per share from $6.30-$6.50. The midpoint remained unchanged at $6.40, reflecting greater visibility into full-year results. The company maintained its year-end occupancy outlook of 86.2-87.8%. It also continues to expect same-property NOI to decline 8.5-10.5% and rental rates on renewals and re-leasing to decrease 1-9%.

How Have Estimates Been Moving Since Then?It turns out, estimates revision have trended downward during the past month.

VGM ScoresAt this time, Alexandria Real Estate Equities has a poor Growth Score of F, however its Momentum Score is doing a bit better with a D. However, the stock has a grade of B on the value side, putting it in the second quintile for value investors.

Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Alexandria Real Estate Equities has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.

Performance of an Industry PlayerAlexandria Real Estate Equities belongs to the Zacks REIT and Equity Trust - Other industry. Another stock from the same industry, Ventas (VTR - Free Report) , has gained 1.3% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.

Ventas reported revenues of $1.73 billion in the last reported quarter, representing a year-over-year change of +21.7%. EPS of $0.14 for the same period compares with $0.87 a year ago.

Ventas is expected to post earnings of $0.99 per share for the current quarter, representing a year-over-year change of +12.5%. Over the last 30 days, the Zacks Consensus Estimate has changed +0.1%.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Ventas. Also, the stock has a VGM Score of D.

Key Takeaways Sysco targets 6-7% fiscal 2027 sales growth and 9-11% adjusted earnings growth.SYY expects about $100M in fiscal 2027 cost savings as sourcing, routing and technology support margins.Sysco sees 2.5% local case growth, while traffic, inflation, pricing and Restaurant Depot risks remain. Sysco Corporation (SYY - Free Report) enters fiscal 2027 with a firmer growth outlook after ending fiscal 2026 with improving local case trends, productivity gains and continued International momentum. Management expects those drivers to support faster earnings growth.

The case is not one-sided. Cost growth, soft restaurant traffic, competitive pricing and uncertainty around the proposed Restaurant Depot transaction leave execution as the key test for investors.

Sysco's Fiscal 2027 Growth Case Is StrengtheningSysco expects fiscal 2027 sales growth of 6-7% to approximately $90 billion. Adjusted earnings are projected to increase 9-11%, with adjusted EPS of $5.02-$5.12.

That outlook builds on positive case growth exiting fiscal 2026 and further productivity gains. Excluding the benefit of a 53rd week, management expects earnings growth at the high end of its long-term growth algorithm despite a soft industry backdrop.

SYY's Margin Gains Depend on Cost ExecutionManagement expects about $100 million of in-year cost savings in fiscal 2027, representing roughly $160 million on a run-rate basis. Gross-margin expansion is also expected as sourcing, routing and technology initiatives contribute.

The hurdle is expense discipline. Full-year fiscal 2026 adjusted operating expenses increased 5.1%, faster than gross-profit growth of 4.5%, showing how continued investments in sales capacity and distribution infrastructure can limit operating leverage.

Sysco's Local and International Engines Add SupportU.S. local case growth improved from 0.5% in the first half of fiscal 2026 to 2.9% in the second half. Sysco expects about 2.5% local case growth in fiscal 2027, supported by customer wins, retention and deeper account penetration.

International adjusted operating income rose 15.7% in the fourth quarter, its 11th consecutive quarter of double-digit growth. US Foods Holding Corp. (USFD - Free Report) is a leading foodservice distributor serving about 250,000 customer locations, making it a relevant industry comparator.

Performance Food Group Company (PFGC - Free Report) is one of North America's largest food and foodservice distributors, providing another large-scale reference point for sector demand and execution.

Image Source: Zacks Investment Research

SYY's Valuation Leaves Room for DebateSYY trades at 16.0X forward 12-month earnings, modestly above the sub-industry's 15.1X multiple but below its five-year median of 16.7X. The stock also trades below the Consumer Staples sector's 17.2X and the S&P 500's 20.1X multiples.

That positioning does not make the shares obviously cheap, but it also leaves less evidence of an extended valuation. Investors are paying a slight premium to the sub-industry while getting a multiple below broader reference points.

Sysco Still Faces Traffic, Pricing and Deal RisksFiscal 2027 guidance assumes industry traffic remains broadly similar to fiscal 2026 and inflation runs around 1.5-2%. A weaker traffic environment or higher inflation could pressure case volumes and complicate margin targets.

Competitive pricing can also require Sysco to absorb some costs while it continues investing in service and capacity. Currency swings and the proposed Restaurant Depot transaction add uncertainty, with the FTC having issued a second request and Sysco still targeting a fiscal third-quarter 2027 closing.

SYY's Near-Term Signal Meets Mixed Style ScoresSysco's improving earnings outlook supports a more constructive view, but the margin, traffic and transaction risks argue for a measured approach rather than an aggressive entry. The stock currently carries a Zacks Rank #2 (Buy), which provides a favorable near-term earnings-revision signal. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Value Score of B is supportive for value-oriented investors, while the Growth Score of C and Momentum Score of D are less favorable. The VGM Score of C shows that the stock does not have broad A or B-level strength across value, growth and momentum, keeping the overall setup balanced.

Jupiter Topco LLC purchased a new position in The Kroger Co. (NYSE:KR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 76,501 shares of the company’s stock, valued at approximately $4,248,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. SGL Investment Advisors Inc. bought a new position in Kroger during the second quarter valued at $2,764,000. Allstate Corp grew its stake in shares of Kroger by 108.5% in the 4th quarter. Allstate Corp now owns 47,991 shares of the company’s stock worth $2,998,000 after buying an additional 24,976 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Kroger in the 2nd quarter worth about $76,633,000. Conning Inc. increased its holdings in shares of Kroger by 10,178.7% in the 4th quarter. Conning Inc. now owns 507,459 shares of the company’s stock worth $31,706,000 after buying an additional 502,522 shares during the last quarter. Finally, North Dakota State Investment Board purchased a new stake in shares of Kroger during the 4th quarter valued at about $1,299,000. 80.93% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In A number of equities research analysts have issued reports on the company. Morgan Stanley decreased their price objective on Kroger from $73.00 to $67.00 and set an “equal weight” rating on the stock in a research report on Monday, June 22nd. The Goldman Sachs Group reissued a “buy” rating and set a $82.00 target price on shares of Kroger in a research report on Friday, June 19th. Wells Fargo & Company set a $58.00 price target on Kroger in a report on Monday, June 22nd. Wall Street Zen downgraded Kroger from a “buy” rating to a “hold” rating in a research report on Saturday, June 20th. Finally, Barclays set a $61.00 price objective on shares of Kroger and gave the stock an “equal weight” rating in a research note on Monday, June 22nd. Ten analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $71.75.

View Our Latest Research Report on Kroger Kroger Trading Up 0.7% NYSE:KR opened at $57.94 on Wednesday. The firm has a 50 day moving average of $57.69 and a 200 day moving average of $64.26. The company has a quick ratio of 0.39, a current ratio of 0.79 and a debt-to-equity ratio of 2.43. The Kroger Co. has a 52 week low of $54.15 and a 52 week high of $76.58. The stock has a market capitalization of $35.50 billion, a price-to-earnings ratio of 34.08, a PEG ratio of 1.54 and a beta of 0.41.

Kroger (NYSE:KR – Get Free Report) last issued its quarterly earnings results on Thursday, June 18th. The company reported $1.58 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.01). Kroger had a return on equity of 44.33% and a net margin of 0.71%.The business had revenue of $46.12 billion for the quarter, compared to analyst estimates of $45.59 billion. During the same period in the previous year, the company posted $1.49 earnings per share. The business’s revenue for the quarter was up 2.2% on a year-over-year basis. Kroger has set its FY 2026 guidance at 5.100-5.30 EPS. As a group, sell-side analysts anticipate that The Kroger Co. will post 5.21 earnings per share for the current fiscal year.

Kroger Increases Dividend The company also recently announced a quarterly dividend, which was paid on Tuesday, September 1st. Investors of record on Saturday, August 15th were issued a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 2.7%. This is a positive change from Kroger’s previous quarterly dividend of $0.35. The ex-dividend date of this dividend was Friday, August 14th. Kroger’s dividend payout ratio is presently 91.76%.

Kroger Company Profile (Free Report)

The Kroger Co (NYSE: KR) is one of the largest supermarket operators in the United States, offering a wide range of retail grocery and related services. Founded in Cincinnati in 1883 by Bernard Kroger, the company operates a portfolio of supermarket and multi-department store banners and provides customers with fresh foods, packaged groceries, deli and bakery items, meat and seafood, produce, and prepared foods. Kroger’s stores commonly include pharmacy services and fuel centers, positioning the company as a broad-based neighborhood retail destination for everyday needs.

In addition to traditional in-store retailing, Kroger manufactures and distributes a variety of private-label brands and operates its own food production and supply-chain facilities.

Featured Articles Five stocks we like better than Kroger Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery

Receive News & Ratings for Kroger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kroger and related companies with MarketBeat.com's FREE daily email newsletter.

Jupiter Topco LLC bought a new stake in Invitation Home (NYSE:INVH – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 140,383 shares of the company’s stock, valued at approximately $4,243,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sequoia Financial Advisors LLC grew its position in Invitation Home by 2.4% during the 4th quarter. Sequoia Financial Advisors LLC now owns 20,257 shares of the company’s stock worth $563,000 after acquiring an additional 484 shares during the last quarter. LPL Financial LLC increased its stake in shares of Invitation Home by 0.7% in the fourth quarter. LPL Financial LLC now owns 73,676 shares of the company’s stock valued at $2,047,000 after buying an additional 503 shares during the period. Commonwealth Equity Services LLC increased its stake in shares of Invitation Home by 5.1% in the fourth quarter. Commonwealth Equity Services LLC now owns 10,575 shares of the company’s stock valued at $294,000 after buying an additional 516 shares during the period. Northwestern Mutual Wealth Management Co. raised its holdings in Invitation Home by 21.6% in the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 3,171 shares of the company’s stock valued at $93,000 after buying an additional 564 shares during the last quarter. Finally, SCS Capital Management LLC raised its holdings in Invitation Home by 3.4% in the 4th quarter. SCS Capital Management LLC now owns 17,908 shares of the company’s stock valued at $498,000 after buying an additional 582 shares during the last quarter. Institutional investors own 96.79% of the company’s stock.

Wall Street Analyst Weigh In Several equities research analysts have recently weighed in on INVH shares. Raymond James Financial upgraded shares of Invitation Home from a “market perform” rating to an “outperform” rating and set a $32.00 price objective for the company in a research report on Monday, May 18th. JPMorgan Chase & Co. boosted their target price on shares of Invitation Home from $33.00 to $34.00 and gave the company an “overweight” rating in a report on Tuesday, August 25th. Keefe, Bruyette & Woods upped their price target on shares of Invitation Home from $29.00 to $31.00 and gave the company a “market perform” rating in a research report on Wednesday, August 5th. Citigroup reiterated a “buy” rating on shares of Invitation Home in a report on Thursday, August 6th. Finally, BMO Capital Markets lifted their price objective on Invitation Home from $32.00 to $35.00 and gave the stock a “market perform” rating in a research report on Monday, June 15th. Ten investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $32.53.

View Our Latest Stock Report on Invitation Home Invitation Home Trading Down 0.1% Shares of Invitation Home stock opened at $29.12 on Wednesday. The company has a market capitalization of $17.20 billion, a P/E ratio of 26.72, a price-to-earnings-growth ratio of 4.16 and a beta of 0.83. The stock has a fifty day simple moving average of $29.98 and a 200 day simple moving average of $28.18. Invitation Home has a 12-month low of $24.25 and a 12-month high of $31.16. The company has a current ratio of 0.02, a quick ratio of 0.02 and a debt-to-equity ratio of 0.44.

Invitation Home (NYSE:INVH – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.34. The company had revenue of $747.55 million for the quarter, compared to analysts’ expectations of $731.13 million. Invitation Home had a return on equity of 7.22% and a net margin of 23.13%.The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.48 EPS. Invitation Home has set its FY 2026 guidance at 1.920-1.980 EPS. On average, sell-side analysts anticipate that Invitation Home will post 1.89 earnings per share for the current fiscal year.

Invitation Home Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Friday, July 17th. Shareholders of record on Thursday, June 25th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date of this dividend was Thursday, June 25th. Invitation Home’s payout ratio is presently 110.09%.

Invitation Home Profile (Free Report)

Invitation Homes (NYSE: INVH) is a real estate investment trust that specializes in the ownership, operation and leasing of single-family rental homes across the United States. The company focuses on acquiring suburban and urban-adjacent single-family residences and managing them as rental properties for households seeking professionally managed, long-term housing alternatives to traditional homeownership or multifamily rentals.

Operationally, Invitation Homes is involved in the full lifecycle of the single-family rental business: sourcing and acquiring homes, performing renovations and ongoing maintenance, marketing and leasing properties, and providing property management and resident services.

Featured Articles Five stocks we like better than Invitation Home Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery Want to see what other hedge funds are holding INVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invitation Home (NYSE:INVH – Free Report).

Receive News & Ratings for Invitation Home Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitation Home and related companies with MarketBeat.com's FREE daily email newsletter.

AI software company UiPath Inc. (NYSE:PATH) looks to continue its strong stock momentum from the last month, with second-quarter financial results coming Thursday after market close.

Here are the earnings estimates, analyst ratings and key items to watch.

UiPath Q2 Earnings EstimatesAnalysts expect UiPath to report second-quarter revenue of $397.95 million, up from $362.00 million in last year’s second quarter, according to data from Benzinga Pro.

The company has beaten revenue estimates from analysts in five straight quarters and in nine of the last 10 quarters overall.

While the revenue estimate would mark a year-over-year gain, it comes after three straight quarters of revenue of $411 million or more.

Guidance from the company calls for second-quarter revenue to be in a range of $395 million to $400 million.

Analysts expect UiPath to report second-quarter earnings of 15 cents per share, in line with last year’s total of 15 cents per share in the second quarter.

The company missed analyst estimates for earnings per share in the first quarter, but has beaten estimates in nine of the last 10 quarters overall.

Read Next

UiPath Analyst Ratings and Price TargetsThere are not many analyst ratings on UiPath ahead of quarterly results. Here are the latest ratings and price targets:

UBS: Maintained Neutral rating, raised price target from $12 to $19 RBC Capital: Maintained Sector Perform rating, raised price target from $12 to $15 Key Items to WatchUiPath comes into the earnings report with shares up 36% over the last month. The recent gains top the year-to-date performance of 14.6%. UiPath stock is currently at its highest level since December 2025 and could be ready to set new 52-week highs with a strong report.

The first quarter saw mixed results, with the company missing earnings per share for the first time in more than 10 quarters. Revenue beat analyst estimates, continuing a strong streak of beats.

In the first quarter, UiPath reported annual recurring revenue of $1.901 billion, up 12% year-over-year. This will be a key figure to watch to see whether recurring revenue from customers continues to grow.

The company expects annual recurring revenue to be in a range of $1.929 billion to $1.934 billion in the second quarter.

Company management said agentic products are moving from pilot to production, which could set UiPath up for increased revenue opportunities going forward.

With shares ready to break out, analysts and investors will likely be looking for a double beat, strong guidance and an update on agentic products.

UiPath Stock Price ActionUiPath stock is down 2% to $17.76 on Wednesday versus a 52-week trading range of $9.20 to $19.84.

Read Next

Photo: Ian Dewar Photography / Shutterstock

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Zscaler (ZS -3.78%) reports its fiscal fourth-quarter results after the market's close tomorrow, Sept. 3. While several cybersecurity stocks are near all-time highs, Zscaler has been out of favor recently, as management gave cautious guidance in its previous earnings report.

However, with two of the largest cybersecurity companies, CrowdStrike (NASDAQ: CRWD) and Palo Alto Networks (NASDAQ: PANW), recently reporting results that show AI is boosting cybersecurity demand, could Zscaler beat the modest expectations investors have for its business?

Image source: The Motley Fool.

As we've seen numerous times this earnings season, beating top- and bottom-line expectations isn't always enough. With that in mind, here are some of the things I'll be watching tomorrow when the company reports.

3 Things I'll be watchingFirst of all, Zscaler doesn't exactly have a high bar to clear. Management's previous guidance calls for roughly 22% year-over-year revenue growth in the fiscal fourth quarter, and the company has a strong recent history of outperforming its own expectations. In the fiscal third quarter, Zscaler reported 25% growth in both revenue and ARR, as well as its highest-ever adjusted operating margin. But while I'll be watching this, it isn't my main focus.

In the company's fiscal third-quarter report, the problem wasn't Zscaler's top and bottom line. That isn't why the stock fell sharply after the report. It was the guidance. The company's initial fiscal 2027 outlook called for annual recurring revenue growth to slow to just 16%-17%. With CrowdStrike just reporting its highest net new ARR growth rate ever, a significant guidance raise from Zscaler could be a major catalyst for the stock.

Premium Feature

Moneyball Superscore

76/100

Today's Change

(

-3.78

%) $

-6.74

Current Price

$

171.63

After all, a big reason CrowdStrike is trading near all-time highs is that management issued fiscal 2027 guidance calling for net new ARR growth of 630 basis points (6.3 percentage points) above the previous level.

I'll also be watching the RPO (remaining performance obligation), which essentially tells us Zscaler's revenue backlog. This grew 30% in the fiscal third quarter to $6.5 billion, and if the company continues to book revenue faster than its top-line reflects, it could indicate healthy growth acceleration in the near future.

It's all about the outlookAs we've seen with several other AI-focused businesses in this earnings season, simply beating expectations isn't enough. As I'm writing this, Palo Alto's stock is falling despite topping estimates. The biggest factor is what management says about the future. If the company confirms a deceleration in growth, even a strong top-line beat might not matter. On the other hand, strong guidance would likely make investors far more confident heading into the new fiscal year.

The acceleration of agentic AI and the threats that come with it have forced enterprises to bump up spending on cyber defenses. Zscaler's two largest peers just issued earnings reports that clearly show this. The company is well-positioned, with its zero-trust architecture, to lead the way in securing agentic workflows. If the numbers it reports tomorrow, along with its forward guidance and management commentary, indicate that the company is gaining traction in the agentic AI cybersecurity push, the stock could react very positively.

Key Takeaways Rocket Lab strengthens its space platform across launch services, space systems and national security.RKLB advances Neutron with qualification testing, hardware integration and Archimedes engine testing.Rocket Lab's Mynaric and Motiv acquisitions boost optical communications, robotics and vertical integration. Rocket Lab Corporation (RKLB - Free Report) shares have risen 43.7% over the past year, outperforming the Zacks Aerospace-Defense Equipment industry’s growth of 2.7%. The company is driving growth by expanding its end-to-end space platform, advancing Neutron, and strengthening launch and space systems capabilities. The Mynaric and Motiv acquisitions, along with rising U.S. national security opportunities, support long-term growth.

Image Source: Zacks Investment Research

Meanwhile, stocks like Leonardo DRS, Inc. (DRS - Free Report) and TransDigm Group Inc. (TDG - Free Report) have underperformed the industry during the same period. Shares of DRS and TDG have fallen 9.8% and 9.6%, respectively.

With RKLB shares gaining over the past year, investors may have positive views. Let’s examine the factors and assess the stock’s investment prospects to make an informed decision.

Factors Boosting RKLB Stock's GrowthRocket Lab is strengthening its end-to-end space platform across launch services and space systems. Electron and HASTE support commercial and government missions, while Neutron is expected to expand its addressable market into medium-lift constellation and defense launches. The Mynaric and Motiv acquisitions further enhance optical communications, satellite mechanisms and robotics capabilities, strengthening vertical integration.

The company made significant progress in the second quarter of 2026, advancing Neutron qualification testing, first-flight hardware integration, Archimedes engine testing and reusable fairing systems. Rocket Lab had completed 87 Electron missions and delivered more than 250 spacecraft through June 30. Its backlog reached $2.36 billion, providing greater visibility into future revenues.

In August 2026, Rocket Lab announced its onboarding to the U.S. Space Force’s NITE-STAR IDIQ program, which has a $981 million ceiling. The selection allows Rocket Lab to compete for future task orders covering space and ground systems, digital environments and mission operations, expanding its opportunities in national security space and strengthening its position as an end-to-end space solutions provider.

Earnings Estimates for RKLB StockThe Zacks Consensus Estimate for RKLB’s 2026 earnings per share (EPS) indicates a rise of 44.44% over the past 60 days.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Leonardo DRS’ 2026 EPS calls for a jump of 5.38% in the past 60 days. The estimate for TransDigm Group’s fiscal 2026 EPS implies an increase of 2.47% over the same period.

Debt Position of RKLBCurrently, Rocket Lab’s total debt to capital is 0.83%, lower than the industry’s average of 61.47%. It indicates that the company can run its business efficiently with much lower debt levels than its industry peers.

Image Source: Zacks Investment Research

Liquidity Position of RKLBRKLB has a current ratio of 5.48 compared with its industry’s average of 2.06. The ratio, being more than one, indicates that RKLB possesses sufficient capital to pay off its short-term debt obligations. 

Image Source: Zacks Investment Research

Its industry peers, Leonardo DRS and TransDigm Group, also maintain current ratios above one. DRS has a current ratio of 1.92, while TDG holds 3.02.

RKLB Stock Trades at a PremiumRocket Lab is currently trading at 31.3X, a premium compared to its industry’s 7.64X on a forward 12-month Price/Sales basis.

Image Source: Zacks Investment Research

What Should an Investor Do?Rocket Lab is benefiting from expanding launch and space systems capabilities, progress on Neutron and rising national security opportunities. The Mynaric and Motiv acquisitions further strengthen vertical integration, while its growing backlog and broader end-to-end space platform support long-term growth prospects.

Given RKLB’s strong share price performance, improving earnings estimates, lower debt levels and solid liquidity position, investors may consider including this Zacks Rank #2 (Buy) stock in their portfolios at current levels. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways WPM's Antamina mine produced 2.3 million ounces of silver in Q2'26, up 56% y/y.The Antamina PMPA lifted Wheaton Precious Metals' attributable silver to 67.5% from April 1, 2026.WPM expects output weighted to H2 and targets 1.2 million GEOs annually by 2030. Wheaton Precious Metals Corp. (WPM - Free Report) has delivered solid performance so far this year. The upside was driven by the addition of the precious metals purchase agreement (“PMPA”) with BHP Group Limited (BHP - Free Report) .

The BHP Antamina precious metals purchase agreement (“PMPA”) became effective as of April 1, 2026, lifting Wheaton Precious Metals’ attributable silver to 67.5% and adding another 33.75% of payable silver until delivery thresholds step down. The $4.3-billion Antamina stream deal with BHP Group marks Wheaton Precious Metals’ largest transaction, adding long-life silver exposure and requiring ongoing payments equal to 20% of the spot silver price.

Antamina’s production fell short of WPM’s expectations in the second quarter of 2026 due to lower silver grades and the decision to pull a planned July maintenance shutdown forward into June. Despite the headwinds, the mine’s production increased 56% year over year to 2.3 million ounces of silver.

WPM’s attributable gold-equivalent production increased 13.8% year over year to 414,755 ounces in the first six months of 2026. The company reaffirmed the 2026 attributable production guidance of 860,000-940,000 GEOs, with output expected to be weighted to the second half of 2026. This indicates a rise of 30% at the mid-point from the 2025 production of 692,000 ounces. Wheaton Precious Metals expects production of 1.2 million GEOs by 2030 and averaging around that level through 2035. The BHP Group Antamina PMPA, alongside the ramp-up of newer mines and contributions from assets, will likely drive the upside.

Performance of Wheaton Precious Metals’ PeersSSR Mining Inc. (SSRM - Free Report) remains the third-largest U.S. gold producer, anchored by the two high-quality, long-lived assets, Marigold in Nevada and CC&V in Colorado. In 2026, Marigold’s production is expected to be 55-60% weighted to the second half, as higher grades stacked midyear are expected to lift production later in the year. 

SSR Mining produced 101,959 gold-equivalent ounces in the second quarter of 2026. SSR Mining expects 2026 production to be 450,000-535,00 ounces, with production weighted to the second half of 2026.

AngloGold Ashanti PLC (AU - Free Report) gold production dipped 4% year over year in the first half of 2026, reflecting the sale of Serra Grande mine in December 2025. Lower second-quarter production at Obuasi due to a contractor fatality in April 2026 and planned mine sequencing and maintenance across certain operations also led to the decline. However, AngloGold Ashanti expects second-half 2026 production to be higher than that reported in the first half. AngloGold Ashanti maintains gold production expectations between 2.80 million and 3.17 million ounces for 2026.

WPM’s Price Performance, Valuation & EstimatesWheaton Precious Metals shares have jumped 43.5% in a year compared with the industry's 50.6% growth. In comparison, the Zacks Basic Materials sector and the S&P 500 have returned 33.6% and 23.2%, respectively.

Image Source: Zacks Investment Research

WPM is currently trading at a forward 12-month price-to-earnings multiple of 31.24X, a premium to the industry average of 17.16X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for Wheaton Precious Metals’ 2026 sales is $3.66 billion, indicating a 58.1% year-over-year jump. The consensus mark for the year’s earnings is pegged at $4.79 per share, suggesting a year-over-year rally of 58.1%.

The Zacks Consensus Estimate for 2027 sales implies a 0.3% year-over-year rise. The same for earnings suggests a dip of 4.8%.

EPS estimates for 2026 and 2027 have moved south over the past 60 days.

Image Source: Zacks Investment Research

The WPM stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways Interactive Brokers' client DARTs rose 23% y/y to 4.28 million in August 2026.IBKR gained from market volatility tied to monetary policy, inflation and geopolitical developments.Interactive Brokers' net new accounts jumped 49% y/y, while total accounts increased 35%. Interactive Brokers (IBKR - Free Report) announced the Electronic Brokerage segment’s (deals with the clearance and settlement of trades for individual and institutional clients globally) performance metrics for August 2026. Supported by a favorable trading environment, total client Daily Average Revenue Trades (DARTs) increased 23% year over year to 4,276,000.

In the reported month, investor activity benefited from sizable moves across equity, fixed-income and commodity markets amid shifting expectations for U.S. monetary policy, inflation concerns and geopolitical developments. Toward the end of August, renewed U.S.-Iran tensions pushed oil prices and interest rates higher, while the Federal Reserve policy expectations shifted following hawkish commentary, creating additional market uncertainty and trading opportunities.

Beyond a favorable trading backdrop, Interactive Brokers benefited from company-specific strengths. Its low-cost structure, competitive margin rates, ongoing product enhancements, streamlined account-opening process and highly efficient operating model supported strong client acquisition. At the end of August, net new accounts were 143,200, which jumped 49% year over year and total customer accounts touched 5.46 million, increasing 35%.

If we look at the other metrics, total options contracts were 138.3 million in August 2026, up 2% year over year. Futures contracts increased 1% to 17.4 million. Client equity was $962.8 billion, which jumped 35% year over year. Client credit balances of $185.6 billion increased 27%, whereas the company's customer margin loan balance of $101.5 billion grew 41%.

IBKR’s efforts to broaden its addressable market by adding new products and capabilities will likely further deepen client engagement and increase wallet share. At the same time, the company’s efforts to expand its international platform positions it to capitalize on growing cross-border investing activity and wealth creation across global markets. Together, these factors are expected to aid sustained revenue growth. Over 2020-2025, Interactive Brokers’ total net revenues saw a compound annual growth rate of 22.8%, aided by higher interest income, commission revenues and business expansion.

Business Diversification Efforts of IBKR’s PeersIBKR’s key competitors, Charles Schwab (SCHW - Free Report) and Robinhood Markets, Inc. (HOOD - Free Report) , have also been continuously rolling out products and services to bolster market share.

Schwab is diversifying beyond brokerage through wealth management, banking, asset management, lending and alternative investments. This is broadening Schwab’s revenue base and deepening client relationships. These offerings attract more assets and encourage clients to consolidate finances on its platform, supporting higher engagement and creating additional opportunities for trading activity.

Robinhood is diversifying beyond traditional stock trading through crypto, retirement, credit cards, advisory services, prediction markets and international expansion. This broader ecosystem attracts new customers and assets while increasing platform engagement, creating cross-selling opportunities at Robinhood. This is supporting higher trading activity across equities, options, futures and digital assets.

IBKR’s Price Performance & Zacks RankShares of Interactive Brokers have rallied 30.2% in the past six months compared with the industry’s growth of 19%.

Image Source: Zacks Investment Research

Currently, Interactive Brokers sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Key Takeaways Centene shares surged 117% in a year as pricing, cost controls and underwriting trends improved.CNC raised 2026 premium and service revenue guidance to $173-$177B while its HBR improved.CNC trades below industry and key-peer forward P/E levels despite sharply improving 2026 earnings estimates. Centene Corporation (CNC - Free Report) shares have jumped 117% over the past year, far ahead of the industry’s 22.3% growth. The S&P 500 has gained 20.6% over the same period, while peers UnitedHealth Group Incorporated (UNH - Free Report) and Elevance Health, Inc. (ELV - Free Report) have returned 28.8% and 25.4%, respectively.

Much of Centene’s rally reflects a recovery from a depressed level. The stock came under heavy pressure after the company withdrew its 2025 earnings guidance in July 2025. Management found that Marketplace members were considerably sicker than expected, which reduced projected risk-adjustment revenues and hurt earnings expectations. Rising medical costs in both Marketplace and Medicaid plans added to the concern and weakened confidence in the company’s outlook.

The picture has improved since then. Profitability stabilized faster than investors expected, corrective pricing in the Marketplace business began to take hold, and Centene reduced exposure to plans that were not priced adequately. Management also raised its outlook several times. As a result, investors have moved from fearing prolonged losses and uncontrolled medical costs to expecting better margins, firmer pricing and more predictable earnings.

One-Year Price Performance: CNC, UNH, ELV, Industry & S&P 500 Image Source: Zacks Investment Research

Operating Trends Point to a RecoveryCentene’s second-quarter health benefits ratio (HBR) improved 340 basis points year over year to 89.6%. Premium revenues increased 4.4% to $43.6 billion, supported by higher premium yields, growth in the prescription drug plan business and rate increases across Medicaid and Marketplace products.

The balance sheet also strengthened. Long-term debt fell 7.6% from year-end 2025 to $16 billion, while cash and cash equivalents rose 35% to $24.2 billion. Net cash provided by operations reached $8 billion in the first half of 2026, up 142.4% from the prior-year period, although favorable timing contributed to the increase.

Management raised its 2026 premium and service revenue guidance to $173-$177 billion from $171-$175 billion. The company now expects a HBR of 90.5-91.3% for 2026, compared with 91.9% in 2025 and 88.3% in 2024. The projected improvement suggests that recent pricing and cost actions are starting to support underwriting results.

Earnings Expectations Have Turned Sharply HigherThe Zacks Consensus Estimate calls for 2026 earnings of $4.89 per share, up 135.1% from the previous year. Analysts expect earnings to rise another 9.2% in 2027 to $5.34 per share.

Revenue growth is expected to remain modest. The consensus estimate points to revenues of $196.29 billion in 2026, up 0.8%, followed by a slight decline to $192.58 billion in 2027. This outlook shows that the recovery is centered more on margins and execution than on rapid sales growth.

Centene has also topped earnings estimates in each of the past four quarters, producing an average surprise of 151.3%.

CNC’s ValuationThe rebound has lifted Centene’s valuation. CNC now trades at 12.56X forward earnings, above its five-year median of 11.31X. Even so, the multiple remains below the industry average of 15.69X. It also trails UnitedHealth’s 18.31X and Elevance Health’s 14.11X. Centene carries a Value Score of A, indicating that the stock still offers a reasonable mix of valuation and earnings potential.

Image Source: Zacks Investment Research

Centene currently trades below the average analyst price target of $71.94, suggesting an upside of 11.8%. The range is wide, with the high target at $85 and the low at $56, reflecting different risk views.

Risks Have Eased, but They Have Not DisappearedCentene remains dependent on government-sponsored healthcare programs. Its results can therefore shift with changes in federal and state funding, reimbursement rates and regulation across Medicaid, Medicare and Affordable Care Act Marketplace plans.

Expenses deserve attention. Total operating costs rose 5.5% in 2023, 5.8% in 2024 and 26.6% in 2025. They increased another 6.6% year over year in the first half of 2026. Pricing actions and tighter cost controls should help, but elevated medical expenses and continued investment could slow the pace of margin gains.

Capital efficiency remains another weak spot. Centene’s trailing 12-month return on capital is 6.8%, below the industry average of 9.9%, showing room for better capital efficiency.

Why Centene’s Recovery Could ContinueSeveral trends support the longer-term outlook. An aging population and rising chronic-disease prevalence should support long-term demand across Centene’s health plans.

Centene is also reshaping its membership mix. Total membership declined to 25.9 million at the end of the second quarter as the company reshaped its book, but prescription drug plan membership rose 12.2% year over year, while Individual and Commercial Group membership rose 10.5%, showing growth in selected areas of the portfolio.

The company is strengthening fraud prevention and payment integrity through AI-based analytics that can flag unusual claims earlier and improve oversight. It is also using advanced analytics in medical-cost forecasting, pricing and operating decisions.

Centene is working with states to secure rates that better match member needs, utilization trends and the risk profile of the population after eligibility redeterminations. These steps, together with firmer Marketplace pricing and tighter cost control, give the company a clearer path to steadier margins.

Should Investors Buy CNC Stock Now?Centene’s sharp rebound increasingly has fundamental support rather than relying on momentum alone. Corrective Marketplace pricing, better Medicaid rate alignment, tighter cost controls and stronger PDP growth are helping margins recover, while repeated guidance increases point to better earnings visibility.

Risks tied to medical costs, regulation and government funding remain, and the stock is no longer as cheap as it was a year ago. Still, earnings estimates are moving higher, underwriting trends are improving, and valuation remains below key peers. With these factors supporting further upside, Centene currently sports a Zacks Rank #1 (Strong Buy), making the stock worth considering for investors. You can see the complete list of today’s Zacks #1 Rank stocks here.

Jupiter Topco LLC purchased a new stake in Flowserve Corporation (NYSE:FLS – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 57,767 shares of the industrial products company’s stock, valued at approximately $4,285,000.

Other institutional investors have also recently made changes to their positions in the company. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Flowserve in the 2nd quarter worth about $34,000. Global Retirement Partners LLC bought a new position in shares of Flowserve during the 2nd quarter worth approximately $38,000. Atlas Capital Advisors Inc. purchased a new position in shares of Flowserve in the 4th quarter worth approximately $36,000. BOKF NA purchased a new position in shares of Flowserve in the 3rd quarter worth approximately $28,000. Finally, Keating Financial Advisory Services Inc. bought a new position in shares of Flowserve in the second quarter valued at approximately $48,000. Institutional investors own 93.93% of the company’s stock.

Wall Street Analysts Forecast Growth FLS has been the topic of a number of recent analyst reports. TD Cowen lowered Flowserve from a “buy” rating to a “hold” rating and dropped their price target for the stock from $85.00 to $70.00 in a report on Wednesday, June 24th. Weiss Ratings lowered Flowserve from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, August 25th. Stifel Nicolaus lifted their target price on Flowserve from $92.00 to $94.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. The Goldman Sachs Group set a $82.00 price target on shares of Flowserve in a research report on Thursday, July 30th. Finally, Robert W. Baird set a $93.00 price objective on shares of Flowserve in a research report on Friday, July 31st. Six research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $86.60.

Get Our Latest Stock Report on FLS Flowserve Stock Down 3.2% FLS stock opened at $76.56 on Wednesday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.58 and a current ratio of 2.15. The company has a market capitalization of $9.73 billion, a price-to-earnings ratio of 26.86, a PEG ratio of 1.76 and a beta of 1.25. Flowserve Corporation has a fifty-two week low of $48.71 and a fifty-two week high of $92.41. The stock has a fifty day moving average of $75.09 and a 200-day moving average of $77.01.

Flowserve (NYSE:FLS – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.09. The company had revenue of $1.17 billion during the quarter, compared to analyst estimates of $1.16 billion. Flowserve had a return on equity of 21.42% and a net margin of 8.01%.The firm’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.91 EPS. Flowserve has set its FY 2026 guidance at 4.050-4.200 EPS. As a group, equities research analysts predict that Flowserve Corporation will post 4.1 earnings per share for the current year.

Flowserve Dividend Announcement The firm also recently declared a quarterly dividend, which will be paid on Friday, October 9th. Stockholders of record on Friday, September 25th will be given a $0.22 dividend. The ex-dividend date of this dividend is Friday, September 25th. This represents a $0.88 annualized dividend and a dividend yield of 1.1%. Flowserve’s payout ratio is 30.88%.

Flowserve Company Profile (Free Report)

Flowserve Corporation (NYSE: FLS) is a leading provider of fluid motion and control products and services. The company designs, manufactures and services engineered and industrial pumps, mechanical seals, valves and related flow management equipment. Flowserve’s offerings are utilized across a broad spectrum of end markets, including oil and gas, power generation, chemical processing, water management, pharmaceutical and semiconductor manufacturing, as well as mining and general industrial applications.

Flowserve’s product portfolio encompasses a wide range of centrifugal and positive displacement pumps, high-performance control valves, butterfly and ball valves, as well as mechanical seals and seal support systems.

See Also Five stocks we like better than Flowserve Dutch Bros Sell-Off Creates a Growth Opportunity NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat Is Abercrombie & Fitch’s Hot Streak Just Getting Started? Medtronic’s Stars Are Aligning for a Price Recovery

Receive News & Ratings for Flowserve Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Flowserve and related companies with MarketBeat.com's FREE daily email newsletter.

Brown Forman NYSE: BF.A said its first-quarter fiscal 2027 results were largely in line with expectations, as growth from ready-to-drink products and Jack Daniel’s Tennessee Blackberry helped offset pressure in used barrel sales, tequila and several developed international markets.

President and Chief Executive Officer Lawson Whiting said innovation remains a key growth engine for the company amid selective consumer spending and continued softness in the broader spirits market. Brown-Forman reaffirmed its full-year outlook, including expectations for approximately flat organic net sales and a 3% to 5% decline in organic operating income.

Get Brown Forman alerts:

“Innovation is creating meaningful growth opportunities across our portfolio,” Whiting said, pointing to New Mix, the company’s RTD portfolio and Jack Daniel’s Tennessee Blackberry as major contributors during the quarter.

RTDs and Blackberry Support Sales New Mix delivered strong double-digit organic net sales growth in Mexico, where it has benefited from consumer interest in flavor, convenience and affordability. The product’s U.S. demand has exceeded Brown-Forman’s expectations since launch, according to Whiting, and the company is expanding into additional markets while adding flavors and package options.

New Mix is currently available in nine U.S. states, particularly areas with substantial Mexican American populations, Whiting said during the question-and-answer session. Despite its limited distribution, it has become the eighth-largest contributor to the RTD category in Nielsen data, he said.

Brown-Forman’s el Jimador Spritz also had a strong U.S. start. Based on recent Nielsen data, the company’s RTD portfolio contributed about one point of value growth to its overall U.S. performance.

Jack Daniel’s Tennessee Blackberry, meanwhile, contributed more than two points of U.S. value growth based on Nielsen takeaway trends. The flavor is now available in more than 30 international markets, with strong growth in Brazil, France and the United Arab Emirates. Brown-Forman is supporting the launch with broader distribution and additional pack sizes, while also extending the product into an RTD Jack Daniel’s Tennessee Blackberry & Lemonade offering.

Whiting said the Tennessee Blackberry rollout was designed as a two-year launch. The first year centered largely on the U.S. 750-milliliter format, while the current phase includes international expansion and additional U.S. sizes.

Barrel Sales, Tequila and International Markets Remain Pressured Growth initiatives were partly offset by a more than 60% decline in organic net sales for Brown-Forman’s non-branded and bulk business, primarily used barrel sales. Whiting said used barrel sales have fallen from more than $100 million two years ago to about $30 million, as demand from Scotch and Irish whiskey producers has remained below prior elevated levels.

The company expects used barrel sales to remain under pressure, though management expects the year-over-year dollar impact on net sales to moderate through the rest of fiscal 2027.

Brown-Forman’s full-strength tequila portfolio, including Herradura and el Jimador, posted a low-teens organic net sales decline. Whiting said the company is working to improve performance through marketing, clearer brand positioning and commercial execution.

Management cited improving U.S. takeaway trends for el Jimador, which has gained standing within the $15 to $30 tequila price range. Herradura faces a more difficult backdrop in higher-priced tequila segments, although Whiting said Brown-Forman plans to introduce new initiatives for the brand.

Emerging international markets generated 9% organic net sales growth, led by Mexico and the UAE. The UAE benefited from shipment timing, while Brazil faced a difficult comparison following prior-year supply chain disruptions and continued to run below last year despite recovering trends.

Developed international markets declined 8% organically. Australia grew 4%, helped by ordering patterns for Jack Daniel’s Tennessee Whiskey and RTD innovation, including the Australia-exclusive Jack Daniel’s Tennessee Serve whiskey-and-cola RTD. However, consumer demand remained weak across Germany, France and the U.K. In Canada, U.S.-produced spirits remained off shelves in most provinces, and Brown-Forman assumes the restrictions will continue for the rest of the fiscal year.

Profitability and Cash Flow Gross margin expanded 40 basis points to 60.2%, primarily due to lower costs related to timing and favorable portfolio changes. The improvement was partly offset by foreign exchange, including the stronger Mexican peso, and product mix pressure from fast-growing RTDs.

Chief Financial Officer Jim Peters said the first-quarter margin level could represent the high point for the year. The company expects higher-cost whiskey inventory produced during a period of elevated inflation to increasingly affect results, along with higher input costs and the impact of lower production volumes.

Organic advertising expense declined 4%, primarily due to timing, while organic selling, general and administrative expenses increased 5%, largely reflecting organizational changes aimed at reducing complexity and accelerating decision-making.

Reported operating income declined 3%. Organic operating income increased 4%. Earnings per share rose 6% to $0.38. Cash flow from operations increased $13 million to $173 million. Free cash flow increased $32 million to $161 million. The company repaid €300 million of 1.2% senior notes that matured July 7, 2026. Brown-Forman continues to expect fiscal 2027 capital expenditures of $60 million to $70 million and an effective tax rate of roughly 20% to 22%.

Leadership Transition and Outlook Whiting reiterated that he plans to retire after a successor is named, following nearly 30 years with Brown-Forman. The board’s Corporate Governance and Nominating Committee is considering internal and external candidates, and the company has not provided a timeline. Whiting expects to support the transition in an advisory capacity after a successor is appointed.

Management said it remains encouraged by U.S. trends, though Whiting characterized the improvement as gradual. The company expects depletions to exceed shipments for the full fiscal year as shipment timing benefits from the prior-year distributor transition and Tennessee Blackberry launch normalize.

“We feel good about our business,” Whiting said. “We feel more confident about our business today, and we’re going to continue to grow and do it on our own and create the most value that we can.”

About Brown Forman (NYSE:BF.A)Brown-Forman Corporation manufactures, bottles, imports, exports, markets, and sells various alcoholic beverages. It provides spirits, wines, whiskey spirits, whiskey-based flavored liqueurs, ready-to-drink and ready-to-pour products, ready-to-drink cocktails, vodkas, tequilas, champagnes, brandy, bourbons, and liqueurs. The company offers its products primarily under the Jack Daniel's, Woodford Reserve, Canadian Mist, GlenDronach, BenRiach, Glenglassaugh, Old Forester, Early Times, Slane Irish Whiskey, Coopers' Craft, el Jimador, Herradura, New Mix, Pepe Lopez, Antiguo, Finlandia, Korbel Champagne, and Sonoma-Cutrer brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Brown Forman Right Now?Before you consider Brown Forman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brown Forman wasn't on the list.

While Brown Forman currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

It has been about a month since the last earnings report for Inspire Medical Systems (INSP - Free Report) . Shares have lost about 4.1% in that time frame, underperforming the S&P 500.

But investors have to be wondering, will the recent negative trend continue leading up to its next earnings release, or is Inspire due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important catalysts.

Inspire Medical Q2 Earnings Beat Estimates, ’26 View Raised

Inspire Medical Systems, Inc. reported second-quarter 2026 adjusted earnings per share of 14 cents, down 58.8% year over year. The figure beat the Zacks Consensus Estimate of a loss of 22 cents by 163.6%.

GAAP earnings per share in the quarter were 1 cent compared to GAAP loss per share of 12 cents in the year-ago quarter.

INSP’s Q2 Revenues in Detail

Inspire Medical registered revenues of $200.6 million in the second quarter, down 7.6% year over year. The figure beat the Zacks Consensus Estimate by 2.9%.

The decline in sales was primarily caused by a decrease in U.S. revenues due to coding and reimbursement challenges. This was partly offset by an increase in international revenues.

As of June 30, 2026, INSP operated 280 U.S. sales territories and employed 301 field clinical representatives compared with 295 territories and 275 representatives at the end of 2025.

INSP’s Q2 Revenue Mix Reflects U.S. Pressure

In the second quarter, U.S. revenues totaled $187.3 million, down 9.6% year over year. Management attributed the weakness primarily to the evolving coding and reimbursement environment, which slowed prior-authorization activity and procedure volumes.

International revenues totaled $13.3 million, up 33.6% year over year. The overseas gain partly offset the domestic decline, but the United States remained the dominant contributor to quarterly sales.

INSP’s Margin Analysis

In the second quarter, Inspire Medical’s gross profit decreased 6% year over year to $171.5 million. The gross margin expanded 150 basis points to 85.5%, primarily driven by a higher sales mix of the Inspire V system.

Selling, general and administrative expenses decreased 7.7% year over year to $147.3 million. Research and development expenses declined 5.8% to $24.7 million. Operating expenses of $171.9 million decreased 7.4% year over year.

Adjusted operating profit decreased 66.8% year over year to $3.2 million. The adjusted operating margin contracted 280 basis points to 1.6%.

Inspire Medical’s Financial Position

Inspire Medical exited the second quarter of 2026 with cash and cash equivalents and short-term investments of $320.7 million compared with $283.8 million at the end of first-quarter 2026.

Cumulative net cash provided by operating activities at the end of second-quarter 2026 was $36.1 million, compared with the cumulative net cash used in operating activities of $4 million a year ago.

Inspire Medical Raises 2026 Outlook

Inspire Medical has updated its revenue and earnings per share outlook for 2026.

The company raised its revenue guidance to $835 million-$875 million from the previously projected $825 million-$875 million. The Zacks Consensus Estimate is pegged at $851.2 million.

INSP now expects adjusted earnings per share for 2026 in the range of $1.05-$1.45, up from the prior guidance of $0.75-$1.25. The company projects an adjusted operating margin of 4-6%. The Zacks Consensus Estimate is pegged at $1.24 per share.

How Have Estimates Been Moving Since Then?Since the earnings release, investors have witnessed a downward trend in estimates revision.

The consensus estimate has shifted -49.19% due to these changes.

VGM ScoresAt this time, Inspire has a average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.

Overall, the stock has an aggregate VGM Score of C. If you aren't focused on one strategy, this score is the one you should be interested in.

OutlookEstimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Inspire has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months.

Performance of an Industry PlayerInspire belongs to the Zacks Medical Info Systems industry. Another stock from the same industry, Tempus AI (TEM - Free Report) , has gained 32.4% over the past month. More than a month has passed since the company reported results for the quarter ended June 2026.

Tempus reported revenues of $382.49 million in the last reported quarter, representing a year-over-year change of +21.6%. EPS of -$0.04 for the same period compares with -$0.22 a year ago.

Tempus is expected to post a loss of $0.07 per share for the current quarter, representing a year-over-year change of +36.4%. Over the last 30 days, the Zacks Consensus Estimate has changed +3.3%.

The overall direction and magnitude of estimate revisions translate into a Zacks Rank #3 (Hold) for Tempus. Also, the stock has a VGM Score of F.